ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
2,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
5,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
6,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
7,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
11,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
13,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
14,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
15,1,Headache,Headaches NEC,Headaches,Nerv,N
15,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
16,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
18,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
19,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
19,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
20,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
20,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
21,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
22,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
23,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
24,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
25,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
27,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
28,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
29,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
30,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
30,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
32,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
33,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
34,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
35,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
35,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
36,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
36,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
36,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
38,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
38,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
39,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
40,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
40,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
40,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
41,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
42,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
42,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
42,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
43,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
44,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
44,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
45,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
45,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
46,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
52,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
53,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
54,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
54,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
55,1,Headache,Headaches NEC,Headaches,Nerv,N
55,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
55,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
56,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
56,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
56,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
57,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
58,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
59,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
60,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
60,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
60,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
60,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
61,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
61,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
61,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,1,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
63,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
64,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
65,1,Deafness,Hearing losses,Hearing disorders,Ear,N
65,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
65,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
66,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
67,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
68,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
69,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
69,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
69,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
69,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
69,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
70,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
71,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
71,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
72,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
73,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
74,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
74,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
74,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
75,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
76,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
76,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
77,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
78,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
78,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
80,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
80,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
81,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
83,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
83,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
84,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
84,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
84,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
84,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,6,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
84,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
84,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
85,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
86,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
86,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
87,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
88,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
88,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
89,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
90,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
90,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
90,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
91,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
92,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
92,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
93,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
93,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
94,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
95,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
96,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
97,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
97,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
98,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
99,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
100,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
100,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
100,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
101,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
101,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
101,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
102,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
103,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
103,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
103,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
103,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
104,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
104,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
105,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
106,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
106,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
106,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
107,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
108,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
109,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
110,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
111,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
112,2,Headache,Headaches NEC,Headaches,Nerv,N
112,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
112,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
112,5,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
112,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
112,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
113,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
115,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
116,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
117,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
118,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
118,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
118,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
118,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
118,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
119,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
120,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
120,2,Headache,Headaches NEC,Headaches,Nerv,N
120,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
121,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
122,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
122,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
123,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
123,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
124,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
124,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
125,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
125,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
125,3,Headache,Headaches NEC,Headaches,Nerv,N
126,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
128,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
128,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
129,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
130,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
131,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
131,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
131,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
131,4,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
132,1,Sturge-Weber syndrome,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
133,1,Pseudoporphyria,Bullous conditions,Epidermal and dermal conditions,Skin,N
134,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
134,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
135,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
135,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
136,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
136,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
136,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
137,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
137,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
137,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
137,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,3,Headache,Headaches NEC,Headaches,Nerv,N
138,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
139,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
139,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
139,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
140,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
142,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
143,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
144,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
144,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
144,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
145,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
145,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
145,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
145,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
145,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
145,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
146,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
146,2,Headache,Headaches NEC,Headaches,Nerv,N
146,3,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
147,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
147,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
147,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
147,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
149,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
150,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
150,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
150,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
150,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
151,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
152,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
152,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
153,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
154,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
155,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
157,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
158,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
159,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
160,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
161,1,Primary hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
162,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
162,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
162,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
163,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,2,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
163,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
164,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
164,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
165,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
166,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
167,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
168,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
169,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
170,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
171,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
171,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
171,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
172,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
174,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
175,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
175,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
175,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
175,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
175,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
177,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
177,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
179,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
179,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
180,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,3,Immobile,Disability issues,Lifestyle issues,SocCi,N
180,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
181,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
182,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
183,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
184,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
185,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
185,2,Subdiaphragmatic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
186,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,2,Testicular seminoma (pure),Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
187,1,Testicular seminoma (pure),Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
188,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
189,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
190,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
191,1,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
192,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
192,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
193,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
193,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
193,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
193,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
193,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
194,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
195,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
196,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
197,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
198,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
199,1,Adenocarcinoma metastatic,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
199,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
200,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
201,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
202,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
203,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
204,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
205,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
206,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
207,1,Carcinoid tumour pulmonary,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
208,1,Deafness,Hearing losses,Hearing disorders,Ear,N
208,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
209,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
209,2,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
209,3,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
209,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
209,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
209,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
210,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
210,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
211,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
211,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
212,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
212,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
212,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
212,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
212,5,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
213,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
214,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
214,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
214,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
214,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
216,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
217,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
218,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
219,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
219,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
220,1,Myopathy,Myopathies,Muscle disorders,Musc,N
220,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
221,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
221,2,Lung carcinoma cell type unspecified recurrent,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
222,1,Abnormal clotting factor,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
222,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
222,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
222,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
223,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
223,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
223,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
224,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
225,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
226,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
227,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
228,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
229,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
229,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
229,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
230,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
231,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
232,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
232,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
232,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
233,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
233,2,Papilloma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
233,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
234,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
234,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
235,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
236,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
236,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
236,3,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
236,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
236,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
237,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
237,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
237,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
238,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
238,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
238,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
238,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
238,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
239,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
239,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
240,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
240,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
240,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
240,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
241,2,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
241,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
242,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
243,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
244,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
244,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
244,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
245,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
245,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
245,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
246,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
247,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
248,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
248,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
249,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
250,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
251,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
252,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
252,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
252,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
252,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
252,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
252,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
252,7,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
253,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
254,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
255,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
256,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
258,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
259,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
260,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
260,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
261,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
262,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
262,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
262,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
262,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
263,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
263,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
264,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
265,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
266,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
266,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
266,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
266,4,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
267,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
267,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
267,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
267,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
268,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
268,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
269,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
270,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
271,1,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
272,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
273,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
274,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
275,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
276,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
277,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
278,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
279,1,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
280,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
281,1,Blood thyroid stimulating hormone abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
281,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
281,3,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
282,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
282,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
282,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
282,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
283,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
283,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
284,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
284,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
285,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
285,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
285,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
285,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
286,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
286,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
287,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
288,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
288,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
288,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,4,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
288,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
288,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
288,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
289,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
290,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
291,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
292,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
292,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
293,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
294,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
295,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
295,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
295,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
295,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
295,6,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
295,7,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
295,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
295,9,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
295,10,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
296,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
296,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
296,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,4,Palindromic rheumatism,Arthropathies NEC,Joint disorders,Musc,N
296,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
298,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
298,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
298,3,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
299,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
300,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
300,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
301,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
302,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
302,2,Foetal malposition,Foetal position and presentation abnormalities,Foetal complications,Preg,N
302,3,Umbilical cord around neck,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
303,1,Foetal malposition,Foetal position and presentation abnormalities,Foetal complications,Preg,N
303,2,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
304,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
304,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
305,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
305,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
306,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
306,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
307,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
308,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
309,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
310,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
311,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
311,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
312,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
313,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
314,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
315,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
315,2,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
315,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
315,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
316,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
317,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
317,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
317,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
318,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
318,2,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
319,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
320,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
320,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
320,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
320,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
320,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
320,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
320,7,Steroid therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
320,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
321,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
322,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
323,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
324,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
325,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
326,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
327,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
327,2,Headache,Headaches NEC,Headaches,Nerv,N
327,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
327,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
327,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
327,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
328,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
328,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
328,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
329,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
330,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
331,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
331,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
332,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
333,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
333,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
333,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
333,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
333,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
333,6,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
333,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
333,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
335,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
335,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
336,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
337,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
338,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
339,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
339,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
339,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
341,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
341,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
341,3,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
342,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
342,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
343,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
343,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
343,3,Neutralising antibodies positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
343,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
344,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,3,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
344,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
345,1,Anovulatory cycle,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
345,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
345,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
346,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
346,2,Ultrasound abdomen abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
347,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
348,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
348,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
348,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
349,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
349,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
349,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
349,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
349,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
349,6,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
349,7,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
349,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
349,9,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
349,10,Porphyria non-acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
349,11,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
349,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
350,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
351,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
352,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
352,2,Headache,Headaches NEC,Headaches,Nerv,N
352,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
353,2,Headache,Headaches NEC,Headaches,Nerv,N
353,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
353,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
354,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
354,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
354,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
354,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
354,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
354,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
354,8,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
354,9,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
354,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
355,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
355,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,4,Headache,Headaches NEC,Headaches,Nerv,N
355,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
355,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
355,7,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
355,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
355,9,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
355,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
355,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
355,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
357,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
357,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
357,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
358,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
359,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
359,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
359,3,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
360,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
361,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
361,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
362,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
362,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
362,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
362,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
363,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
364,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
365,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
365,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
366,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
367,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
367,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
367,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
368,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
368,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
368,3,Ventricle rupture,Myocardial disorders NEC,Myocardial disorders,Card,N
369,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
370,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
370,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
371,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
372,1,Autoimmune thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
372,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
372,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
372,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
372,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
373,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
373,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
374,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
374,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
374,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
375,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
376,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
376,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
376,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
377,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
378,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
379,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
380,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
380,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
381,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
382,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
383,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
384,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
384,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
385,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
386,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
386,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
387,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
387,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
387,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
387,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
387,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
388,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
388,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
388,3,Cellulitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
388,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
389,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
390,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
391,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
392,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
393,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
393,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
394,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
395,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
395,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
396,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
396,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
397,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
397,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
397,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
398,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
398,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
398,3,Walking disability,Disability issues,Lifestyle issues,SocCi,N
399,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
399,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
399,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
399,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
399,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
399,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
399,7,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
400,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
401,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
402,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
403,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
403,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
403,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
404,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
404,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
404,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
404,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
405,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
405,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
405,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
406,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
406,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
406,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
407,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
408,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
408,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
409,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
410,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
411,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
411,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
411,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
411,4,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
411,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
411,6,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
411,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
411,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
411,9,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
411,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
412,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
413,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
414,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
414,2,Coagulation test abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
414,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
414,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
414,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
414,6,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
415,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
415,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
416,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
416,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
416,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
417,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
418,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
419,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
420,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
420,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
420,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
420,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
420,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
420,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
420,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
421,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
421,2,Headache,Headaches NEC,Headaches,Nerv,N
421,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
421,4,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
421,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
421,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
422,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
422,2,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
422,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
422,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
423,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
423,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
423,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
423,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
423,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
423,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,7,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
423,8,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
423,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
424,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
425,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
425,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
425,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
425,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
425,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
425,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
426,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
427,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
427,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
427,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
427,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
427,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
427,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
428,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
429,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
430,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
430,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
430,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
431,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
432,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
433,1,Headache,Headaches NEC,Headaches,Nerv,N
434,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
435,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
435,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
436,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
437,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
437,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
437,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
438,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
438,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
438,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
439,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
439,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
439,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
439,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
440,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
440,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
440,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
440,4,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
440,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
440,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
441,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
442,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
443,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
443,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
443,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
443,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
444,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
446,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
447,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
447,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
448,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
449,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
449,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
450,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
451,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
452,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
452,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
453,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
454,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
455,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
455,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
455,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
456,2,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
457,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
458,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
459,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
459,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
460,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
461,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
461,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
461,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
461,4,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
461,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
462,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
463,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
464,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
465,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
466,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
467,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
467,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
467,3,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
467,4,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
467,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
468,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
468,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
468,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
468,5,Lung adenocarcinoma stage I,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
468,6,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
468,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
468,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
468,9,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
469,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
469,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
469,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
469,5,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
470,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
470,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
471,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
471,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
472,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
472,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
474,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
475,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
475,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
475,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,4,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
475,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
476,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
476,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
476,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
476,4,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
476,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
477,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
477,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
477,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
477,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
477,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
477,6,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
477,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
478,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
479,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
480,1,Female reproductive neoplasm,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
480,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
481,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
482,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
483,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
483,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
484,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
485,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
485,2,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
485,3,Intracranial mass,Structural brain disorders NEC,Structural brain disorders,Nerv,N
485,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
486,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
486,2,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
486,3,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
487,1,Haemangioma of liver,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
488,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
488,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
488,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
488,5,Lung adenocarcinoma stage I,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
488,6,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
488,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
488,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
488,9,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
489,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
490,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
490,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
491,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
491,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
491,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
491,4,Scleroderma renal crisis,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
491,5,Systemic scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
492,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
493,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
493,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
493,3,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
493,4,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
493,5,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
493,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
494,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
494,2,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
494,3,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
494,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
494,5,Headache,Headaches NEC,Headaches,Nerv,N
494,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
494,7,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
495,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
495,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
495,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
496,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
496,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
496,3,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
496,4,Headache,Headaches NEC,Headaches,Nerv,N
496,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
496,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
498,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
498,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
499,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
499,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
500,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
501,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
501,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
502,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
502,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
503,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
503,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
504,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
504,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
504,3,Headache,Headaches NEC,Headaches,Nerv,N
504,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
504,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
504,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
505,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
505,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
506,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
506,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
506,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
506,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
507,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
507,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
508,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
509,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
510,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
510,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
510,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
512,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
513,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
514,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
514,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
515,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
516,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
516,3,Headache,Headaches NEC,Headaches,Nerv,N
516,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
516,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
516,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
516,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
516,8,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
516,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
516,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
517,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
518,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
519,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
519,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
520,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
520,2,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
520,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
520,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
520,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
520,7,Headache,Headaches NEC,Headaches,Nerv,N
520,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
521,1,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
522,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
523,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
523,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
524,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
524,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
524,5,Headache,Headaches NEC,Headaches,Nerv,N
524,6,Headache,Headaches NEC,Headaches,Nerv,N
524,7,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
524,8,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
524,9,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
524,10,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
524,11,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
524,12,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
524,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
524,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
524,15,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
524,16,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
525,1,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
525,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
526,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
527,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
527,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
528,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
529,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
529,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
529,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
529,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
529,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
530,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
530,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
530,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
530,4,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
530,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
530,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
530,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
530,8,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
531,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
531,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
531,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
532,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
532,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
533,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
534,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
534,2,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
534,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
534,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
535,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
536,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
536,2,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
537,1,Glomerulonephritis minimal lesion,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
537,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
538,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
538,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
538,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
539,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
539,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
539,4,Headache,Headaches NEC,Headaches,Nerv,N
539,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
539,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
539,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
539,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
539,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
540,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
540,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
541,1,Hypobarism,Atmospheric pressure injuries,Injuries by physical agents,Inj&P,Y
542,1,Endometrial hyperplasia with cellular atypia,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
542,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
543,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
543,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
543,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
543,4,Device material issue,Device physical property and chemical issues,Device issues,Prod,N
543,5,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
543,6,Headache,Headaches NEC,Headaches,Nerv,N
543,7,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
543,8,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
543,9,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
543,10,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
543,11,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
543,12,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
543,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
543,14,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
543,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
543,16,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
543,17,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
543,18,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
543,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
544,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
545,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
545,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
546,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
546,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
547,1,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
548,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
548,2,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
548,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
548,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
548,5,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
548,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
549,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
550,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
551,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
551,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
553,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
554,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
555,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
556,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
556,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
556,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
556,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
557,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
557,2,Headache,Headaches NEC,Headaches,Nerv,N
557,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
557,4,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
557,5,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
557,6,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
557,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
557,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
557,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
557,10,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
558,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
558,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
558,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
559,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
559,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
559,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
560,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
560,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
561,1,Headache,Headaches NEC,Headaches,Nerv,N
561,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
561,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
561,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
562,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
563,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
563,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
564,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
564,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
565,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
565,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
566,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
567,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
567,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
567,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
567,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
567,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
568,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
568,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
568,3,Headache,Headaches NEC,Headaches,Nerv,N
568,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
569,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
569,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
569,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
570,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
570,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
570,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
570,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
570,5,Headache,Headaches NEC,Headaches,Nerv,N
570,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
570,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
570,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,9,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
571,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
572,1,Salpingo-oophorectomy bilateral,Fallopian tube therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
573,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
573,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
573,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
573,4,Migraine,Migraine headaches,Headaches,Nerv,N
573,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
574,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
575,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
576,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
577,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
578,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
578,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
578,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
578,4,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
579,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
579,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
579,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
579,4,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
579,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
579,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
580,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
580,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
580,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
580,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
580,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
581,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
581,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
581,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
581,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
581,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
582,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
583,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
584,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
584,2,Fallopian tube abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
584,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
584,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
584,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
584,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
584,7,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
584,8,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
584,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
584,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
584,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
585,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
585,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
585,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
586,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
586,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
586,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
587,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
588,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
589,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
590,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
590,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
590,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
591,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
591,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
591,3,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
591,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
591,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
591,6,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
591,7,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
592,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
593,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
594,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
594,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
595,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
596,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
596,2,Device programming error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
596,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
596,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
596,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
596,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
596,7,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
596,8,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
596,9,Renal hypertrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
596,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
597,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
598,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
598,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
598,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
598,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
598,5,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
599,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
599,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
599,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
599,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
600,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
600,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
601,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
602,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
602,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,4,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
602,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
602,6,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
602,7,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
602,8,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
602,9,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
602,10,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
602,11,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
602,12,Stomach mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
602,13,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
602,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
603,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
604,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
604,2,Kidney perforation,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
604,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
605,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
606,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
607,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
608,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
608,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
608,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
609,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
609,3,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
609,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
609,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
609,6,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
609,7,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
609,8,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
609,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
610,1,Benign hydatidiform mole,Reproductive neoplasms female benign NEC,Reproductive neoplasms female benign,Neopl,N
610,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
611,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
611,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
612,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
612,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
613,1,Cellulitis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
613,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
613,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
613,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
613,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
613,6,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
613,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,8,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
613,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
614,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
614,2,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
615,1,Benign hydatidiform mole,Reproductive neoplasms female benign NEC,Reproductive neoplasms female benign,Neopl,N
615,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
616,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
617,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
618,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
618,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
618,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
618,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
618,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
618,6,Orthopaedic procedure,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
618,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
618,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
619,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
620,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
621,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
621,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
621,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
621,4,Facet joint syndrome,Joint related disorders NEC,Joint disorders,Musc,N
621,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
621,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
622,1,Benign familial pemphigus,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
623,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
623,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
623,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
623,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
624,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
624,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
625,1,Headache,Headaches NEC,Headaches,Nerv,N
625,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
626,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
627,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
627,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
627,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
627,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
627,5,Spigelian hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
628,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
628,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
628,4,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
628,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
628,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
628,7,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
629,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
629,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
630,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
630,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
630,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
630,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
631,1,Benign hydatidiform mole,Reproductive neoplasms female benign NEC,Reproductive neoplasms female benign,Neopl,N
632,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
632,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
632,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
632,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
633,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
634,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
635,1,Headache,Headaches NEC,Headaches,Nerv,N
635,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
636,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
636,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
637,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
637,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
638,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
639,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
640,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
640,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
640,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
640,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
641,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
641,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
641,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
641,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
642,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
643,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
643,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
643,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
644,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
644,2,Hepatitis A,Hepatitis virus infections,Viral infectious disorders,Infec,N
645,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
645,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
645,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
646,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
646,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
647,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
647,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
647,3,Headache,Headaches NEC,Headaches,Nerv,N
647,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
647,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
647,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
647,7,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
647,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
647,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
647,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
647,11,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
648,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
649,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
649,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
649,3,Headache,Headaches NEC,Headaches,Nerv,N
649,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
649,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
649,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
650,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
650,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
650,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
651,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
651,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
651,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
652,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
652,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
652,3,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
652,4,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
652,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
652,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
652,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
652,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
652,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
652,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
652,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
652,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
652,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
652,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
652,15,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
652,16,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
652,17,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
652,18,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
652,19,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
652,20,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
653,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
653,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
654,1,Headache,Headaches NEC,Headaches,Nerv,N
654,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
654,3,Pituitary tumour recurrent,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
654,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
655,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
655,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
655,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
655,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
655,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
656,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
656,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
657,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
657,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
657,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
658,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
658,3,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
658,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
658,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
659,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
659,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
659,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
660,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
661,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
661,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
661,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
661,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
661,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
662,1,Bone neoplasm,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
663,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
663,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
664,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
665,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
665,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
666,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
666,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
667,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
668,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
668,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
668,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
669,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
670,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
670,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
670,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
670,4,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
670,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
671,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
672,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
673,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
673,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
674,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
674,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
675,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
676,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
677,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
678,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
678,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
678,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
678,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
679,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
680,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
680,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
681,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
681,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
681,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
681,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
681,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
681,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
681,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
681,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
681,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
681,10,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,11,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
681,12,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
681,13,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
681,14,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
681,15,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
681,16,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
681,18,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
681,19,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
681,20,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
681,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
681,22,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
681,23,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
681,24,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
681,25,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
681,26,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,27,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
681,28,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
681,29,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,30,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
681,31,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
681,32,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
681,33,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
681,34,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
682,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
682,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
682,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
682,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
682,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
682,6,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
682,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
682,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
682,9,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
683,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
683,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
684,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
685,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
686,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
687,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
687,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
688,1,Granuloma annulare,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
688,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
688,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
688,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
688,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
688,6,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
689,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
689,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
690,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
691,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
692,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
692,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
693,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
694,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
694,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
695,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
696,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
696,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
696,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
697,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
697,2,Device issue,Device issues NEC,Device issues,Prod,N
697,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
697,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
698,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
698,2,Chondrosarcoma,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
699,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
699,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
699,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
700,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
701,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
701,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
701,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
701,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
701,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
701,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
701,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
701,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
702,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
702,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
703,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
703,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
703,3,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
703,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
703,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
704,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
705,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
706,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
706,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
706,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
706,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
707,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
707,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
707,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
707,4,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
707,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
708,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
708,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
708,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
708,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
709,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
709,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
709,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
710,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
710,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
711,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
712,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
712,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
712,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
713,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
713,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
713,4,Headache,Headaches NEC,Headaches,Nerv,N
713,5,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
713,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
713,7,Red cell fragmentation syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
713,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
713,9,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
714,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
714,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
714,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
714,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
714,5,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
714,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
714,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
714,8,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
714,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
715,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
715,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
715,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
715,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
715,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
715,6,Headache,Headaches NEC,Headaches,Nerv,N
715,7,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
715,8,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
715,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
716,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
716,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
717,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
717,2,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
717,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
718,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
718,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
718,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
718,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
719,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
719,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
720,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
720,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
720,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
720,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
721,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
721,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
722,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
723,1,Cervix neoplasm,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
724,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
725,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
725,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
725,3,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
725,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
726,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
726,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
727,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
727,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
727,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
727,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
727,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
728,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
729,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
729,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
729,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
729,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
729,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
730,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
730,2,Intestinal gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
730,3,Myocardial necrosis marker increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
730,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
730,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
731,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
731,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
732,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
733,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
733,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
734,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
734,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
735,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
735,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
735,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
735,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
735,6,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
736,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
736,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
736,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
736,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
736,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
736,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
736,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
736,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
736,9,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
736,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
736,11,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
736,12,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
736,13,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
736,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
737,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
737,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
737,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
738,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
739,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
739,3,Fear of open spaces,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
739,4,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
739,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
740,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
740,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
741,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
741,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
741,3,Scar excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
741,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
741,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
742,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
742,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
742,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
743,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
743,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
743,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
743,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
743,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
743,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
743,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
743,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
744,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
744,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
744,3,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
744,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
745,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
746,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
746,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
746,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
746,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
746,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
746,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
747,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
747,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
748,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
749,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
750,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
750,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
750,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
750,4,Uterine disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
750,5,Vaginal prolapse,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
751,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
751,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
752,1,Morton's neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
753,1,Headache,Headaches NEC,Headaches,Nerv,N
753,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
753,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
753,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
753,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
753,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
753,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
753,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
754,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
755,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
755,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
755,3,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
755,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
756,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
757,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
757,2,Peritonsillar abscess,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
757,3,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
758,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
759,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
760,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
760,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
761,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
761,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
761,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
762,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
763,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
763,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
763,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
764,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
765,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
765,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
765,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
765,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
766,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
766,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
766,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
766,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
766,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
766,6,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
766,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
766,8,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
766,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
766,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
766,11,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
766,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
767,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
768,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
768,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
768,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
768,4,Injection site macule,Injection site reactions,Administration site reactions,Genrl,N
768,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
768,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
768,7,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
768,8,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
769,1,Device issue,Device issues NEC,Device issues,Prod,N
769,2,Headache,Headaches NEC,Headaches,Nerv,N
769,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
770,1,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
770,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
771,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
771,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
771,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
771,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
771,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
771,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
772,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
772,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
772,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
773,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
774,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
775,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
776,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
776,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
776,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
776,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
776,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
777,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
777,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
778,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
778,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
778,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
778,4,Migraine,Migraine headaches,Headaches,Nerv,N
779,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
779,2,Headache,Headaches NEC,Headaches,Nerv,N
779,3,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
779,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
779,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
780,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
781,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
781,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
781,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
781,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
781,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,1,Systolic hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
783,1,Cholelithiasis obstructive,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
784,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
784,2,Breath sounds abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
784,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
784,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
784,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
784,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
784,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
784,8,Mucosal hyperaemia,Mucosal findings abnormal,General system disorders NEC,Genrl,N
784,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
784,10,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
784,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
784,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
785,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
786,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
786,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
786,3,Headache,Headaches NEC,Headaches,Nerv,N
786,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
786,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Neovascularisation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
787,2,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
787,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
787,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
788,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
788,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
789,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
789,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
789,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
789,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
789,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
789,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
790,1,Amyotrophic lateral sclerosis,Motor neurone diseases,Neuromuscular disorders,Nerv,N
790,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
790,3,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
790,4,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
790,5,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
790,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
790,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
790,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
790,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
790,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
790,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
790,12,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
790,13,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
790,14,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
791,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
791,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
791,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
792,1,Amyotrophic lateral sclerosis,Motor neurone diseases,Neuromuscular disorders,Nerv,N
792,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
792,3,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
792,4,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
792,5,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
792,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
792,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
792,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
792,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
792,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
792,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
792,12,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
792,13,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
792,14,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
793,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
793,2,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
793,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
794,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
795,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
795,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
795,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
795,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
796,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
797,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
797,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
797,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
798,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
798,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
799,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
799,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
800,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
800,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
801,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
801,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
801,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
801,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
802,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
802,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
802,3,Pertussis,Bordetella infections,Bacterial infectious disorders,Infec,N
803,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
803,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
803,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
803,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
803,5,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
803,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
803,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
804,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
804,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
804,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
804,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
805,1,Headache,Headaches NEC,Headaches,Nerv,N
805,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
805,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
805,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
805,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
805,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
805,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
805,8,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
805,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
806,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
806,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
806,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
806,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
807,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
807,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
807,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
808,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
809,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
809,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
809,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
809,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
809,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
809,6,Nitrite urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
810,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
810,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
810,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
811,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
811,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
811,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
812,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
812,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
813,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
813,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
813,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
813,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
813,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
813,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
813,7,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
813,8,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
813,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
813,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
814,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
815,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
815,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
815,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
815,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
816,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
816,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
817,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
818,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
818,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
818,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
818,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
818,5,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
818,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
819,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
819,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
820,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
820,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
821,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
822,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
823,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
823,2,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
823,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
823,4,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
823,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
823,6,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
823,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
823,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
824,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
824,2,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
824,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
824,4,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
825,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
825,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
825,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
825,4,Headache,Headaches NEC,Headaches,Nerv,N
825,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
825,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
825,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
825,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
826,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
826,2,Hypertensive nephropathy,Renal hypertension and related conditions,Renal disorders (excl nephropathies),Renal,N
826,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
827,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
828,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
828,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
828,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
828,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
828,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
828,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
829,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
829,2,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
829,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
830,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
830,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
830,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
830,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
830,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
830,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
830,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
831,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
831,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
831,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
831,4,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
831,5,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
832,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
832,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
832,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
832,4,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
833,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
833,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
833,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
833,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
834,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
835,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
836,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
836,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
836,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
836,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
836,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
836,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
837,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
837,2,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
837,3,Fine motor delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
837,4,Gross motor delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
837,5,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
838,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
839,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
840,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
841,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
842,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
842,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
842,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
842,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
842,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
842,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
842,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
842,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
843,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
844,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
844,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
844,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
845,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
846,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
847,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
847,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
847,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
847,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
847,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
847,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
847,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
848,1,Mumps,Mumps viral infections,Viral infectious disorders,Infec,N
849,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
849,2,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,4,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
849,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,6,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,7,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
849,9,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
850,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
851,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
851,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
852,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
853,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
853,2,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
854,1,Headache,Headaches NEC,Headaches,Nerv,N
854,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
854,3,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
854,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
854,5,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
854,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
855,1,Headache,Headaches NEC,Headaches,Nerv,N
855,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
855,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
855,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
855,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
856,1,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
857,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
858,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
858,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
858,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
859,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
859,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
859,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
859,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
860,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,Y
860,2,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
860,3,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
861,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
861,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
862,1,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
863,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
863,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
864,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
864,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
864,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
864,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
865,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
865,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
866,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
866,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
866,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
867,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
868,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
868,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
868,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
868,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
868,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
868,6,Headache,Headaches NEC,Headaches,Nerv,N
868,7,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
868,8,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
868,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
868,10,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
868,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
868,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
868,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
868,14,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
868,15,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
868,16,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
869,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
869,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
869,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
870,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
870,2,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
871,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
871,2,Headache,Headaches NEC,Headaches,Nerv,N
871,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
871,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
872,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
873,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
873,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
873,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
873,4,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
873,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
873,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
873,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
873,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
873,9,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,10,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,11,Headache,Headaches NEC,Headaches,Nerv,N
873,12,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
873,13,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
873,14,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
873,15,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
873,16,Migraine,Migraine headaches,Headaches,Nerv,N
873,17,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
873,18,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
873,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
873,20,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
874,1,Headache,Headaches NEC,Headaches,Nerv,N
874,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
874,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
875,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
875,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
876,1,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
877,1,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
878,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
879,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
879,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
882,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
882,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
883,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
883,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
883,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
883,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
883,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
883,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
883,7,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
884,1,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
884,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
885,1,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
886,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
886,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
887,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
887,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
888,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
888,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
889,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
889,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
889,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
889,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
890,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
890,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
890,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
891,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
892,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,2,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
892,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,1,Gastrointestinal neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
893,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
894,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
894,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
894,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
894,5,Headache,Headaches NEC,Headaches,Nerv,N
894,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
894,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
894,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
894,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
894,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
895,1,Male genital examination abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
895,2,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
895,3,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
896,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
896,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
896,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
896,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
897,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
898,1,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
899,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
902,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
902,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
903,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
904,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
905,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
905,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
905,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
905,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
906,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
907,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
907,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
908,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
908,2,Headache,Headaches NEC,Headaches,Nerv,N
908,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
908,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
908,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
908,6,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
908,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
909,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
910,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
910,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
911,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
911,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
911,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
911,4,Headache,Headaches NEC,Headaches,Nerv,N
911,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
911,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
911,7,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
911,8,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
911,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
911,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
911,11,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
911,12,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
912,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
913,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
913,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
914,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
915,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
915,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
915,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
915,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
916,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
917,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
917,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
918,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
919,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
919,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
919,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
919,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
920,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
920,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
920,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
921,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
921,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
922,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
922,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
923,1,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
923,2,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
923,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
924,1,Ovarian cancer stage III,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
925,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
925,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
926,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
926,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
926,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
926,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
926,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
926,7,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
926,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
926,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
926,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
926,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
926,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
926,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
926,14,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
926,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
927,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
927,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
928,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
928,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
929,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
929,2,Headache,Headaches NEC,Headaches,Nerv,N
929,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
929,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
929,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
929,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
929,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
930,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
930,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
930,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
930,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
931,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
932,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
933,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
933,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
933,3,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
934,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
935,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
936,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
936,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
937,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
938,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
939,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
939,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
940,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
941,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
941,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
942,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
942,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
942,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
943,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
943,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
943,3,Dyspraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
943,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
944,1,Headache,Headaches NEC,Headaches,Nerv,N
945,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
946,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
947,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
948,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
949,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
949,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
950,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
950,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
951,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
951,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
952,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
952,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
952,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
952,4,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
952,5,Headache,Headaches NEC,Headaches,Nerv,N
952,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
952,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
952,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
952,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
953,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
953,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
953,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
954,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
954,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
955,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
955,2,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
956,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
957,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
957,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
958,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
959,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
959,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
960,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
960,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
960,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
961,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
962,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
962,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
962,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
962,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
962,5,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
962,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
963,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
963,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
964,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
965,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
966,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
966,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
967,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
967,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
967,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
967,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
967,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
967,6,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
968,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
968,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
968,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
969,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
970,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
971,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
971,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
972,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
972,2,Arthroscopy,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
972,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
972,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
972,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
972,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
972,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
972,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
972,9,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
973,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
973,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
973,3,Headache,Headaches NEC,Headaches,Nerv,N
973,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
973,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
973,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
973,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
974,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
975,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
975,2,Left ventricular dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
976,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
976,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
976,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
977,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
977,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
977,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
977,4,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
978,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
978,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
978,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
979,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
979,3,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
979,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
979,5,Tachycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
980,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
981,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
982,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
982,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
983,1,Cervix disorder,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
984,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
984,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
985,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
985,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
985,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
985,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
986,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
986,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
986,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
986,7,Headache,Headaches NEC,Headaches,Nerv,N
986,8,Headache,Headaches NEC,Headaches,Nerv,N
986,9,Headache,Headaches NEC,Headaches,Nerv,N
986,10,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
986,11,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
986,12,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,13,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,14,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
987,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
987,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
987,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
987,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
987,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
987,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
987,7,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
987,8,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
987,9,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
987,10,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
988,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
989,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
989,2,Agraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
989,3,Athetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
989,4,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
989,5,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
989,6,Decreased vibratory sense,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
989,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
989,8,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
989,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
989,10,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
989,11,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
989,12,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
989,13,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
989,14,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
989,15,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
989,16,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
989,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
989,18,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
989,19,Neutralising antibodies positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
989,20,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
990,1,Headache,Headaches NEC,Headaches,Nerv,N
991,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
992,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
993,1,Headache,Headaches NEC,Headaches,Nerv,N
993,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
994,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
995,1,Arm amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
995,2,Bladder catheter permanent,Therapeutic bladder catheterisation,Renal and urinary tract therapeutic procedures,Surg,N
995,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
995,4,Mastectomy,Mastectomies,Breast therapeutic procedures,Surg,N
995,5,Mastectomy,Mastectomies,Breast therapeutic procedures,Surg,N
995,6,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
995,7,Polyarteritis nodosa,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
996,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
997,1,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
997,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
997,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
997,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
998,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
999,1,Pelvic haemorrhage,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1000,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1001,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1001,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1001,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1001,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1001,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1001,6,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1001,7,Wisdom teeth removal,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1002,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1002,3,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1002,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1002,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1002,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1002,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1002,8,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1003,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1003,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1004,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1005,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1006,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1007,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1008,1,Band sensation,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1008,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1009,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1009,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1010,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1010,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1011,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1011,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1011,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1011,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1012,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1013,1,Thyroid adenoma,Thyroid neoplasms benign,Endocrine neoplasms benign,Neopl,N
1014,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1015,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1016,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1016,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1016,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1016,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1018,1,Mastectomy,Mastectomies,Breast therapeutic procedures,Surg,N
1019,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1019,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1019,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1020,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1020,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1021,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1022,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1022,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1023,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1024,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1024,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1024,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1024,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1024,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1025,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1026,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1026,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1027,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1028,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1029,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1029,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1029,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1029,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1029,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1030,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1030,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1030,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1031,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1032,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1032,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1033,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1033,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1034,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1034,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1034,3,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1034,4,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1034,5,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1034,6,Headache,Headaches NEC,Headaches,Nerv,N
1034,7,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1034,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1034,9,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1034,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1034,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1034,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1035,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1036,1,Thyroidectomy,Thyroid therapeutic procedures,Endocrine gland therapeutic procedures,Surg,N
1037,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1037,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1037,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1038,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1039,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1039,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1040,1,Carbohydrate antigen 19-9 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1040,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1040,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1041,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1042,1,Acinic cell carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1042,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1043,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1044,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1044,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1045,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1045,2,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1045,3,Migraine,Migraine headaches,Headaches,Nerv,N
1045,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1045,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1046,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1046,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1047,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1048,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1049,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1049,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1050,1,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1051,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1051,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1051,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1051,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1051,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1052,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1053,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1053,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1053,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1054,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1054,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1054,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1054,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1055,1,Retinal aneurysm,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1055,2,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1056,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1056,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1056,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1056,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1057,1,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1057,2,Focal nodular hyperplasia,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
1057,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1057,4,Hepatic adenoma,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
1057,5,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1057,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1057,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1058,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1058,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1059,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1059,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1059,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1060,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1061,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1062,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1062,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1062,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1062,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1062,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1062,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1062,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1062,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1062,9,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1062,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1063,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1063,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1063,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1063,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1063,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1064,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
1065,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1066,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1067,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1068,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1068,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1069,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1069,2,Alpha-1 anti-trypsin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1069,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1069,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1069,5,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1069,6,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1069,7,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1069,8,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1069,9,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1069,10,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1069,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1069,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1069,13,Mean cell haemoglobin concentration decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1069,14,Mean cell haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1069,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1069,16,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1070,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1070,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1070,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1071,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1071,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1071,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1071,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1071,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1071,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1071,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1071,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1072,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1073,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1074,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1074,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1075,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1076,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1076,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1077,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1077,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1077,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1077,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1077,5,Headache,Headaches NEC,Headaches,Nerv,N
1077,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1077,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1077,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1078,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1079,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1079,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1080,1,Foreign body,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1080,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1080,3,Hypertrophic cardiomyopathy,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1080,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1080,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1080,6,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1081,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1081,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1081,3,Migraine,Migraine headaches,Headaches,Nerv,N
1082,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1082,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1082,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1083,1,Epidermolysis bullosa,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
1084,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1085,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1085,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1085,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1085,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1085,5,Procedural anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1085,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,7,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1086,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
1087,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1088,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1088,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1089,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1089,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1090,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1091,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1091,2,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1092,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1092,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1092,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1093,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1093,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1093,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1093,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1094,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1095,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1096,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1097,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1098,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1098,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1099,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1099,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1099,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1099,4,Headache,Headaches NEC,Headaches,Nerv,N
1099,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1099,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1099,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1101,1,Headache,Headaches NEC,Headaches,Nerv,N
1101,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
1101,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
1101,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1101,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1103,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1104,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1105,1,Vascular graft,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
1106,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1107,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1107,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1108,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1108,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1109,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1110,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1110,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1111,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1112,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1113,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1113,2,Calculus bladder,Urinary tract lithiasis NEC,Urolithiases,Renal,N
1113,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1113,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1113,5,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1113,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1113,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1114,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1114,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1115,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1115,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1115,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1115,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1116,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1116,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1117,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1117,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1117,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1117,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1117,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1117,6,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1118,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1118,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1119,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1119,2,Nasal herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1119,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1119,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1119,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1119,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1120,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1120,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1120,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1121,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1122,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1123,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1124,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1125,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1125,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1125,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1125,4,Headache,Headaches NEC,Headaches,Nerv,N
1126,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1127,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1128,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1128,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1128,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1128,4,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1128,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1128,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1129,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1129,2,Brain neoplasm benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
1129,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1129,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1129,5,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1129,6,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1129,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1129,8,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1129,9,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1129,10,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1129,11,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1129,12,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1129,13,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1129,14,Muscle hypertrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1129,15,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1129,16,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1129,17,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1129,18,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1129,19,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1129,20,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1129,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1129,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1130,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1130,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1130,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1131,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1131,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1131,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1131,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1131,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1131,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1131,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1131,8,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1131,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1131,10,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1131,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1131,12,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1132,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1133,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1133,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1134,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1134,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1135,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1136,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1137,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1137,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1138,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1138,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1139,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1140,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1140,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1140,3,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1140,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1140,5,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1142,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1143,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1144,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1145,1,Toe amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1146,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1146,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1146,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1147,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1147,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1147,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1147,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1147,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1148,1,Scan abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1149,1,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1149,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1149,3,Migraine,Migraine headaches,Headaches,Nerv,N
1149,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1149,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1150,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1151,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1151,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1151,3,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
1151,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1152,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1152,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1152,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1153,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1153,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1154,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1154,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1154,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1154,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1154,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1154,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1154,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1155,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1156,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1156,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1157,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1158,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
1158,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1158,3,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
1159,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1159,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1160,1,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1160,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1160,3,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1160,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1161,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1161,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1162,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1163,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1163,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1164,1,Injection site calcification,Injection site reactions,Administration site reactions,Genrl,N
1164,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1164,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
1164,4,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
1164,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1164,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1164,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1165,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1166,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1166,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1167,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1168,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1169,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1170,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1171,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1171,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1172,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1172,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1173,1,Walking disability,Disability issues,Lifestyle issues,SocCi,N
1174,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1174,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1175,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1176,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1176,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1177,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1178,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1179,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1179,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1179,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1180,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1180,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1180,4,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1180,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1180,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1180,7,Injection site laceration,Injection site reactions,Administration site reactions,Genrl,N
1180,8,Ligament rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1180,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1180,10,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1180,11,Peripheral nerve infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1180,12,Peripheral nerve palsy,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1181,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1182,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1183,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1183,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1183,3,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1183,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1184,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1184,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1185,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
1186,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1186,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1187,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1187,2,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1188,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1189,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1190,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1191,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1191,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1191,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1192,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1193,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1194,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1194,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1194,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1195,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1196,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1196,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1196,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1196,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1196,7,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1197,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1197,2,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1198,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1198,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
1198,3,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
1199,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1200,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1201,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1202,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1202,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1202,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1202,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1202,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1202,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1203,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1204,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1204,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1204,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1204,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1204,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1204,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1204,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1205,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1205,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1205,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1205,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1205,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1205,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1206,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1206,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1207,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1207,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1208,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1208,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1208,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1208,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1209,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1210,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1210,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1211,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1211,2,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1211,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1211,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1211,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1212,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1212,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1212,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1212,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1213,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1214,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1216,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1217,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1217,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1217,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1218,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
1218,2,Pneumocephalus,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1218,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1218,4,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1219,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1220,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1220,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1221,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1222,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1222,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1222,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1222,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1222,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1222,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1222,7,Pneumococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
1222,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1222,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1222,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1222,11,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1223,1,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1224,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
1224,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1224,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1225,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1226,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1227,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1228,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1228,2,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1228,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1229,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1229,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1229,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
1229,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1229,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1230,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1231,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1231,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1231,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1231,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1232,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1232,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1232,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1232,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1232,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1233,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1234,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1234,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1235,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1235,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1235,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1235,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1236,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1237,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1238,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1238,2,Uterine disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1239,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1239,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1240,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1241,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1242,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1243,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1243,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1243,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1244,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1244,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1244,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1245,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1245,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1246,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1247,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1248,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1249,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1249,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1249,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1250,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1251,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1252,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1252,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1253,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1253,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1254,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1255,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1255,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1256,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1257,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1257,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1258,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1258,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1258,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1258,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1258,5,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1258,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1258,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1258,8,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1258,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1259,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1259,2,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1259,3,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
1259,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1260,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1260,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1260,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1260,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1261,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1261,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1262,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1262,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1263,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1263,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1264,1,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1264,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1264,3,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1264,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1265,1,Craniopharyngioma,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
1265,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1265,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1266,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1266,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1266,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1266,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1266,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1267,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1267,2,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1267,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1267,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1267,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1267,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1268,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
1268,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1269,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1270,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1270,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1271,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1271,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1271,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1271,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1271,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1271,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1271,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1271,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1271,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1271,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1271,11,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
1271,12,Spondylolisthesis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1271,13,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1271,14,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1272,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1273,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1273,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1273,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1274,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1275,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1276,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1277,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1277,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1277,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1277,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1277,5,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1278,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1278,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1278,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1278,4,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1278,5,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1278,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1278,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1278,8,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1279,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1279,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1279,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1280,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1281,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1282,1,Avian influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1282,2,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1282,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1282,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1282,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1282,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1282,7,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
1283,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1283,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1284,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1284,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1285,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1286,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1287,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1287,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1288,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1289,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1290,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1291,1,Abdominal wall wound,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1291,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1291,3,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1292,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1292,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1293,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
1293,2,Chronic myelomonocytic leukaemia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1294,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1295,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1295,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1295,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1296,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1296,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1296,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1296,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1297,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1297,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1297,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1298,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1298,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1299,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1300,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1300,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1301,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1302,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1303,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1303,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1303,3,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1303,4,Helplessness,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1303,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1303,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1304,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1304,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1304,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1305,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1305,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,1,Fibroadenoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
1306,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1306,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1307,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1308,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1309,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1309,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1309,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1309,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1310,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1311,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1311,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1311,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1311,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1312,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1313,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1313,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1313,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1313,4,Infected neoplasm,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1313,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1313,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1313,7,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1313,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1313,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1313,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1314,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1314,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1315,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1315,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1315,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1315,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1315,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1316,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1317,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1318,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1319,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1319,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1320,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1321,1,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1321,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1321,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1321,4,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1321,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1321,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1322,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1323,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1324,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
1325,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1325,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1325,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1325,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1325,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1326,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1327,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1328,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1328,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1329,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1330,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1331,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1332,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1333,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1333,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1333,4,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1334,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1334,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1335,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1335,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1335,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1336,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1337,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1338,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1338,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1338,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1339,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1340,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1341,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1341,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1342,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1343,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1343,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1343,3,Biopsy liver,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
1343,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1343,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1344,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1345,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1345,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1346,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1346,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1347,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1348,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1348,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1348,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1348,4,Headache,Headaches NEC,Headaches,Nerv,N
1349,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1349,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1349,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1349,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1349,5,Headache,Headaches NEC,Headaches,Nerv,N
1349,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1349,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1349,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1350,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1351,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1351,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1352,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1353,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1353,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1354,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1354,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1355,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1355,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1355,4,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1355,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1355,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1355,7,White blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1356,1,Headache,Headaches NEC,Headaches,Nerv,N
1356,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1356,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1356,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1357,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1358,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1359,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1360,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1360,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1360,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1361,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1361,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1361,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1361,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1361,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1361,6,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1362,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1363,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1364,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1365,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
1365,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1365,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
1366,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1367,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1367,2,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1368,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1368,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1369,1,Headache,Headaches NEC,Headaches,Nerv,N
1369,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1369,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1370,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1371,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1371,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1371,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1371,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1371,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1371,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1372,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1373,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1374,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1374,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1374,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1375,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1375,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1375,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1376,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1376,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1377,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1378,1,Hernia pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1378,2,Hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
1378,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1379,1,Prostate cancer stage III,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1379,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1380,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1381,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1382,1,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1383,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1384,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1385,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1386,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1386,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1387,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1388,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1388,2,Headache,Headaches NEC,Headaches,Nerv,N
1388,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1389,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1390,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1391,1,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1391,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1391,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1392,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1393,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1394,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1395,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1396,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1396,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1396,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1397,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1398,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1399,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1400,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
1401,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1401,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1401,3,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
1402,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1402,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1403,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1404,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1405,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1405,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1405,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1406,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1407,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1408,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1408,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1408,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1410,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1411,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1411,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1412,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1413,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1414,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1414,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1415,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1415,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1416,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1417,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1418,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1418,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1418,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1419,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1419,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1420,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1421,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1422,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1422,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1423,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1423,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1423,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1423,4,Tenosynovitis stenosans,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1423,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1424,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1424,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1425,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1425,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1425,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1425,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1426,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1426,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1427,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1428,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1428,2,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1428,3,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1428,4,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1429,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1430,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1430,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1430,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1431,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1432,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1433,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1433,2,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1434,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1435,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1435,2,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1436,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1437,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1438,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1439,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1439,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1440,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1441,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1442,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1443,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1443,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1443,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1443,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1443,5,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1443,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1443,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1443,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1443,9,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1444,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1445,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1446,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1447,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1448,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1448,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1448,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1448,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1449,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1450,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1450,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1450,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1450,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1450,5,Needle fatigue,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1451,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1451,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1451,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1451,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1452,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1452,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1452,3,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1452,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1452,5,Migraine,Migraine headaches,Headaches,Nerv,N
1452,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1452,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1453,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1453,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1453,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1454,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1455,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1456,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1456,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1456,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1456,4,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
1456,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1457,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1458,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1459,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1460,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1461,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1461,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1462,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1462,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1462,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1462,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1463,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1463,2,Retinal operation,Retinal therapeutic procedures,Eye therapeutic procedures,Surg,N
1464,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1465,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1465,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1465,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1465,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1465,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1466,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1467,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1467,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1468,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1468,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1468,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1469,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1469,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1469,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1470,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1470,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1470,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1470,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1471,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1471,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1472,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1473,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1473,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1473,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1474,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1474,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1474,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1475,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1475,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1475,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1476,1,Encephalomyelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1476,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1476,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1477,1,Vulval cancer,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1478,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1479,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1479,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1479,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1479,4,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1479,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1479,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1479,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1479,8,Oropharyngeal spasm,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1479,9,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1480,1,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1481,1,Carcinoid tumour of the small bowel,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
1482,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1483,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1484,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1484,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1485,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1486,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1487,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1487,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1488,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1488,2,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1488,3,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1489,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1489,2,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1489,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1489,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1489,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1489,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1489,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1489,8,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1489,9,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1489,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1489,11,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1489,12,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1489,13,Myalgia,Muscle pains,Muscle disorders,Musc,N
1489,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1489,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1489,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1490,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1491,1,Migraine,Migraine headaches,Headaches,Nerv,N
1491,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1492,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1492,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1493,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1493,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1493,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1494,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1494,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1494,3,Headache,Headaches NEC,Headaches,Nerv,N
1494,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1494,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1494,6,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1495,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1496,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1497,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1497,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1497,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1497,4,Headache,Headaches NEC,Headaches,Nerv,N
1497,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1497,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1497,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1497,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1497,9,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1498,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1498,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1499,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1500,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1500,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1501,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1501,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1501,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1502,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1503,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1504,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1504,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1504,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1504,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1504,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1504,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1504,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1505,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
1506,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1506,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1506,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1506,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1506,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1507,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
1508,1,Defaecation disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1508,2,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1508,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1508,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1509,1,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1509,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1509,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1509,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1509,5,Medical induction of coma,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
1509,6,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1509,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1510,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1510,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1511,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1511,2,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
1511,3,Myxoid liposarcoma,Liposarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
1512,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1513,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1513,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1513,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1513,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1513,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1513,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1513,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1513,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1513,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1513,10,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1513,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1513,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1513,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1514,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1515,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1516,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1517,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1517,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1518,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1519,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1520,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1521,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1522,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1522,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1522,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1523,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1523,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1523,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1523,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1523,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1523,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1523,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1524,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1524,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1524,3,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1525,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1526,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1526,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1526,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1526,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1526,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1526,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1527,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1528,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1529,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1529,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1529,3,Headache,Headaches NEC,Headaches,Nerv,N
1529,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1530,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1530,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1531,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1531,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1532,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1533,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1533,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1533,3,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1534,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1534,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1534,3,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1535,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1535,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1535,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1536,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1537,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1538,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1538,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1539,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1539,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1539,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1539,4,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1540,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1540,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1540,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1540,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1540,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1540,6,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1540,7,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1541,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1542,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1542,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1542,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1543,1,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1543,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1544,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1546,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1547,1,Disability,Disability issues,Lifestyle issues,SocCi,N
1548,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1549,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1550,1,Biopsy testes abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1550,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1550,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1550,4,Device issue,Device issues NEC,Device issues,Prod,N
1550,5,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1550,6,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1550,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1550,8,Prostatic dysplasia,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
1550,9,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1550,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1551,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1552,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1552,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1553,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1553,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1553,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1553,4,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1554,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1555,1,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1555,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1555,3,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1556,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1557,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1557,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1557,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1557,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1557,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1558,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1558,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1559,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1559,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1559,3,Postpartum sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1560,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1560,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
1560,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1560,5,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1560,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1560,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1561,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1561,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1562,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1562,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1562,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1562,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1563,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1563,2,Headache,Headaches NEC,Headaches,Nerv,N
1563,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1563,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1563,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1563,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1563,7,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1564,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1565,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1565,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1566,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1566,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1567,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1568,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1569,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1569,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1569,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1569,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1569,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1570,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1570,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1571,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1572,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1573,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1573,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1573,3,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
1574,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1575,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1575,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1575,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1576,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1576,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1577,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1577,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1577,3,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1578,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1579,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1580,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1581,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1581,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1581,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1582,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1583,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1584,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1585,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1586,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1586,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1586,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1586,4,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
1586,5,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1587,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1587,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1587,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1587,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1587,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1587,6,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1587,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1587,8,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1587,9,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1587,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1587,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1588,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1589,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1590,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1590,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1590,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1590,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1590,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1590,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1590,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1591,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1592,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1592,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1592,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1592,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1592,5,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1592,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1593,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1593,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1593,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1593,4,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1593,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1594,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1594,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1594,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1594,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1594,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1595,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1596,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1597,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1597,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1597,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1598,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1598,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1598,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1598,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1598,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1598,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1598,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1598,8,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1598,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1599,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1599,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1599,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1599,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1599,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1599,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1599,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1600,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1600,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1600,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1600,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1601,1,Choroid melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
1602,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1602,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1602,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1602,4,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1603,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1604,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1605,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1605,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1605,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1605,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1605,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1605,6,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1605,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1605,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1606,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1606,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1606,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1606,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1606,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1606,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1606,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1606,8,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1606,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1607,1,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
1607,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1608,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1609,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1609,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1610,1,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1611,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1611,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1611,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1612,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1613,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1614,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1615,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1615,2,Headache,Headaches NEC,Headaches,Nerv,N
1615,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1615,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1616,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1617,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1618,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1619,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1620,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1621,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1621,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1622,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1622,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1622,3,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1622,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1622,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1622,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1622,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1623,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1624,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1624,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1625,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1625,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1625,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1625,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1626,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1627,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1627,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1627,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1627,4,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1627,5,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1627,6,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1627,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1627,8,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1627,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1627,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1628,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1628,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1629,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1630,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1631,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1631,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1632,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1632,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1633,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1634,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1635,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1635,2,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1636,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1637,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1638,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1638,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1639,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1640,1,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1641,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1641,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1641,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1641,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1641,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1641,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1642,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1643,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1644,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1645,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1645,2,Band sensation,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1645,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1645,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1646,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1646,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1646,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1646,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1647,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1647,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1647,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1647,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1648,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1649,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1649,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1649,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1649,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1649,5,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1649,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1649,7,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1649,8,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1649,9,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1649,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1649,11,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1650,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1651,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1651,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1651,3,Immunology test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1651,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1651,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1651,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1651,7,Mean cell haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1651,8,Mean cell volume decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1651,9,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1651,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1651,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1651,12,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1652,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1652,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1653,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1653,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1654,1,Rotator cuff repair,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1655,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1656,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1657,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1657,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1657,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1657,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1658,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1658,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1658,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1658,4,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1659,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1660,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1660,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1661,1,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
1662,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1662,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1662,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1662,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1662,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1662,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1662,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1662,8,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1663,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1663,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1664,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1665,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1666,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1666,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1667,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1667,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1667,3,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1667,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1667,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1667,6,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1667,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1667,8,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1667,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1667,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1667,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1667,12,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1667,13,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1667,14,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1667,15,Renal surgery,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1667,16,Urinary tract operation,Urinary tract therapeutic procedures NEC,Renal and urinary tract therapeutic procedures,Surg,N
1668,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1669,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1669,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1669,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1670,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1670,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1671,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1671,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1671,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1671,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1672,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1672,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1673,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1673,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1674,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1674,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1674,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1674,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1674,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1674,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1674,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1675,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1675,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1675,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1675,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1675,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1675,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1675,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1676,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1677,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1677,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1677,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1677,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1677,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1677,6,Headache,Headaches NEC,Headaches,Nerv,N
1677,7,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1677,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1677,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1677,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1677,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1677,12,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1678,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1679,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1680,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1680,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1681,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1681,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1681,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1681,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1681,5,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1681,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1682,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1683,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1684,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1684,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1685,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1685,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1686,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1686,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1686,3,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1686,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1686,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1686,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1686,7,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1687,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1687,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1687,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1687,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1687,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1688,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1688,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1688,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1688,4,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1688,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1688,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1688,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1688,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1688,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1688,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1689,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1689,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1689,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1690,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1690,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1690,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1690,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1691,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1692,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1693,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1693,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1693,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1693,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1693,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1694,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1695,1,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1696,1,Bladder irrigation,Bladder therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1697,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1698,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1699,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1700,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1700,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1700,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1700,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1700,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1700,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1700,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1701,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1702,1,Headache,Headaches NEC,Headaches,Nerv,N
1702,2,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1702,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1703,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1703,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1704,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1704,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1704,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1705,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1706,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1706,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1707,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1708,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1708,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1709,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
1710,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1711,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1711,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1712,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1713,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1714,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1714,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1715,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1715,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1716,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1716,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1717,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1717,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1717,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1717,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1717,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1717,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1717,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1718,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1720,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1720,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1721,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1721,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1722,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1723,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1723,2,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1723,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1723,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1723,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1724,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1724,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1724,3,Headache,Headaches NEC,Headaches,Nerv,N
1724,4,Procedural anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1725,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1726,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1727,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1727,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1727,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1727,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1728,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1729,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1729,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1730,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1730,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1730,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1730,4,Migraine,Migraine headaches,Headaches,Nerv,N
1730,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1731,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1731,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1732,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1733,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1734,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1734,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1734,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1734,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1734,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1734,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1734,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1734,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1734,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1735,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1736,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1736,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1737,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1737,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1738,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1739,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1739,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1739,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1740,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1740,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1740,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1740,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1740,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1740,6,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1740,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1741,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1741,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1741,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1742,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1743,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1744,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1744,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1744,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1745,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1746,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1746,2,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1746,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1746,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1747,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1747,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1747,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1748,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1749,1,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
1749,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1749,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1750,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1751,1,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1752,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1753,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1753,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1753,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1754,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1755,1,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1755,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1755,3,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
1756,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1757,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1757,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1757,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1757,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1757,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1757,6,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1757,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1757,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1757,9,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1757,10,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1757,11,Headache,Headaches NEC,Headaches,Nerv,N
1757,12,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1757,13,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1757,14,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1757,15,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1757,16,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1757,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1757,18,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
1757,19,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1757,20,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1757,21,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1757,22,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1757,23,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1757,24,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1757,25,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1757,26,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1757,27,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1757,28,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1757,29,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1757,30,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1757,31,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1757,32,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1757,33,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1757,34,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1758,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1758,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1759,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1759,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1759,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1759,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1759,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1760,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1761,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1761,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1762,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1762,2,Acne,Acnes,Skin appendage conditions,Skin,N
1762,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1762,4,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1762,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1762,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1762,7,Headache,Headaches NEC,Headaches,Nerv,N
1762,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1762,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1762,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1762,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1762,12,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1762,13,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1762,14,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1762,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1762,16,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1763,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
1764,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1765,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1765,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1765,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1766,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1767,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1767,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1767,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1767,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1768,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1768,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1768,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1769,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1770,1,Headache,Headaches NEC,Headaches,Nerv,N
1770,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1770,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1771,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1772,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1773,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1773,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1773,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1774,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1774,2,Headache,Headaches NEC,Headaches,Nerv,N
1774,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1774,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1774,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1774,6,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1775,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1775,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1775,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1775,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1776,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1776,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1776,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1777,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1778,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1778,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1779,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1780,1,Device issue,Device issues NEC,Device issues,Prod,N
1780,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1780,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1781,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1782,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1783,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1783,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1784,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1784,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1785,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1786,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1787,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1787,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1788,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1788,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1788,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1788,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1788,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1788,6,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1788,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1788,8,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1788,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1788,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1788,11,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1789,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1790,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1791,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1792,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1793,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1794,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1794,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1794,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1795,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1795,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1795,3,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1795,4,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1795,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1795,6,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1795,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1795,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1795,9,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
1795,10,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1795,11,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1795,12,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1795,13,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1796,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1796,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1796,3,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1796,4,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1796,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1796,6,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1796,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1796,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1796,9,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
1796,10,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1796,11,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1796,12,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1796,13,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1797,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1798,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1798,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1798,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1799,1,HER2 positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1800,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1800,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1800,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1801,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1801,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1801,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1801,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1801,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1801,6,Headache,Headaches NEC,Headaches,Nerv,N
1801,7,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1801,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1801,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1801,10,Migraine,Migraine headaches,Headaches,Nerv,N
1801,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1801,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1801,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1801,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1801,15,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1801,16,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1801,17,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1802,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1802,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1803,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1804,1,Headache,Headaches NEC,Headaches,Nerv,N
1804,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1804,3,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1805,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
1805,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1805,3,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1805,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1805,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1805,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1806,1,Headache,Headaches NEC,Headaches,Nerv,N
1806,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1806,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1806,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1807,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1807,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1808,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1809,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1809,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1809,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1809,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1809,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1809,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1810,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1810,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1811,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1811,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1811,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1811,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1812,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1812,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1812,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1812,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1813,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1814,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1815,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1815,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1815,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1815,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1816,1,Renal tumour excision,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1817,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1818,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1818,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1818,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1819,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1819,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1820,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1820,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1820,3,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1820,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1820,5,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1820,6,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1820,7,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1821,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1821,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1821,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1822,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1823,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1824,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1824,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1824,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1825,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1825,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1826,1,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
1827,1,Headache,Headaches NEC,Headaches,Nerv,N
1828,1,Abdominal symptom,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1828,2,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1828,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1828,4,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1828,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1828,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1828,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1828,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1828,9,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1828,10,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1828,11,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1828,12,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1828,13,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1828,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1828,15,Non-alcoholic steatohepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1828,16,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1828,17,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1828,18,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1828,19,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1828,20,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1829,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1830,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1830,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1830,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1830,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1831,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1832,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1832,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1832,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1833,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1834,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1835,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1836,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1837,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1838,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1838,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1838,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1838,4,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1838,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1839,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
1839,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1841,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1842,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1843,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1843,2,Headache,Headaches NEC,Headaches,Nerv,N
1843,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1844,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1844,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1844,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1844,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1844,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1844,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1844,7,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1844,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1845,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1845,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1845,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1845,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1846,1,Device end of service,Device issues NEC,Device issues,Prod,N
1846,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1846,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1847,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1848,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1848,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1848,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1849,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1849,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1850,1,Chromosomal deletion,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1850,2,Fine motor delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1850,3,Foetal exposure via father,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1850,4,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1851,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1851,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1851,3,Cholelithiasis obstructive,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1851,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1851,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1851,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1851,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1852,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1852,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1853,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1853,2,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1853,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1853,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1853,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1853,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1853,7,Headache,Headaches NEC,Headaches,Nerv,N
1853,8,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1853,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1854,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1854,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1854,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1855,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1855,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1855,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1855,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1855,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1855,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1856,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1857,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1858,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1859,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1860,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1860,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1860,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1860,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1860,5,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1861,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1861,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1861,3,Expanded disability status scale score increased,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1861,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1861,5,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1862,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1862,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1863,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1863,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1863,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1864,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1865,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1866,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1866,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1866,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1866,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1866,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1866,6,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1866,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1867,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1867,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1867,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1867,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1867,5,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1867,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1868,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1869,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1870,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1870,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1870,3,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1870,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1871,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1872,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1872,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1872,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1872,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1872,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1872,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1872,7,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1872,8,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1872,9,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
1872,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1873,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1873,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1874,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1874,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1874,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1874,4,Headache,Headaches NEC,Headaches,Nerv,N
1875,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1876,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1876,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1876,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1876,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1876,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1876,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1876,7,Migraine,Migraine headaches,Headaches,Nerv,N
1876,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1876,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1876,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1876,11,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1877,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1878,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1878,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1878,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1879,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1879,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1880,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1880,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1880,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1881,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1882,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1882,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1883,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1883,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1883,3,Headache,Headaches NEC,Headaches,Nerv,N
1883,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1883,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1883,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1883,7,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1884,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1885,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1885,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1885,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1886,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1887,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1887,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1887,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1888,1,Monocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1888,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1888,3,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1888,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1889,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1889,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1890,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1890,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1890,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1891,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1891,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1891,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1891,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1891,5,Headache,Headaches NEC,Headaches,Nerv,N
1891,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1891,7,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1891,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1891,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1891,10,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1892,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1892,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1893,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1894,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1894,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1894,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1894,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1894,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1894,6,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1894,7,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1894,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1894,9,Headache,Headaches NEC,Headaches,Nerv,N
1894,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1894,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1894,12,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1894,13,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1894,14,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1894,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1894,16,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1894,17,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1894,18,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1894,19,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1895,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1895,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1895,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1896,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1896,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1896,3,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
1896,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1896,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1896,6,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1896,7,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1897,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1897,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1898,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1898,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1898,3,Decreased gait velocity,Gait disturbances,General system disorders NEC,Genrl,N
1898,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1898,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1898,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1898,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1898,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1898,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1898,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1898,11,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1898,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1898,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1898,14,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1898,15,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1899,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1899,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1899,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1899,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1899,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1899,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1900,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1900,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1901,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1901,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1901,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1902,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1903,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1903,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1903,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1903,4,Headache,Headaches NEC,Headaches,Nerv,N
1903,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1903,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1903,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1903,8,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1903,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1903,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1903,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1904,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1904,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1904,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1904,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1904,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1904,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1904,7,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1904,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1904,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1904,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1904,11,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1905,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1905,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1905,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1905,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1905,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1905,6,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1905,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1905,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1906,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1907,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1907,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1907,3,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1907,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1907,5,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1907,6,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1907,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1907,8,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1907,9,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1907,10,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1907,11,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1907,12,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1907,13,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1907,14,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1907,15,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1907,16,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1907,17,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1907,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1907,19,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1907,20,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1908,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1908,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1909,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1910,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1910,2,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1911,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1912,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1913,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1913,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1913,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1914,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1914,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1914,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1914,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1914,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1914,6,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1915,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1916,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1917,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1917,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1917,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1917,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1917,5,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1917,6,Headache,Headaches NEC,Headaches,Nerv,N
1917,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1917,8,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1917,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1917,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1917,11,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1917,12,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1918,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1918,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1919,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1919,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1919,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1919,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1919,5,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1919,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1919,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1920,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1920,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1921,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1921,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1921,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1922,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1922,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1922,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1923,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1924,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1924,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1925,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1926,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1927,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1927,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1928,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1928,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1928,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1928,4,Headache,Headaches NEC,Headaches,Nerv,N
1929,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1930,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1931,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1931,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1931,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1931,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1932,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1933,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1933,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1933,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1933,4,Headache,Headaches NEC,Headaches,Nerv,N
1933,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1933,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1933,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1934,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1935,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1935,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1935,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1935,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1935,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1936,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1936,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1936,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1936,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1936,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1937,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1937,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1937,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1937,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1937,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1938,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1938,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1939,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1939,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1939,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1939,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1940,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1941,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1941,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1942,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1942,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1942,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1942,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1942,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1942,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1942,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1943,1,Migraine,Migraine headaches,Headaches,Nerv,N
1944,1,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
1945,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1945,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1945,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1946,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1947,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1947,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1947,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1947,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1947,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1947,6,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1948,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1948,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1948,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1948,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1948,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1948,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1949,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1950,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1950,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1951,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1951,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1951,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1951,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1951,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1951,6,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1951,7,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1951,8,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1951,9,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1951,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1952,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1952,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1953,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1953,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1953,3,Headache,Headaches NEC,Headaches,Nerv,N
1953,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1954,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1954,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1954,3,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
1954,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1955,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1955,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1955,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1956,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1956,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1957,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1957,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1958,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1958,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1959,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1959,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1959,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1960,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1960,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1961,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1961,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1961,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1962,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1963,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1964,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1964,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1964,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1964,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1964,5,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1964,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1965,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1966,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1967,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1967,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1967,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1967,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1968,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1968,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1969,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1969,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1970,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1970,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1970,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1970,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1970,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1971,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1971,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1971,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1971,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1971,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1971,6,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
1971,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1971,8,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1972,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1972,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1973,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1973,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1974,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1974,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1974,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1974,4,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1974,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1974,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1974,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1974,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1974,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1974,10,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1974,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1974,12,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1974,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1974,14,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1974,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1974,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1975,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1975,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1976,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1976,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1976,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1976,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1976,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1977,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1978,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1979,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1981,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1982,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1982,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1982,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1982,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1982,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1983,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1983,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1983,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1984,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1984,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1984,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1984,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1984,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1984,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1984,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1984,8,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1984,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1985,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1986,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1987,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1988,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1988,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1988,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1988,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1988,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1988,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1988,7,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1988,8,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1988,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1988,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1988,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1988,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1989,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1989,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1990,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1990,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1990,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1990,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1991,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1992,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1992,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1992,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1992,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1993,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1993,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1993,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1993,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1994,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1994,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1994,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1995,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1995,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1995,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1995,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1995,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1995,6,Migraine,Migraine headaches,Headaches,Nerv,N
1995,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1995,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1996,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
1996,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1996,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1997,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1997,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1998,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1999,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1999,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2000,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2000,2,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
2001,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2002,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2003,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2004,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2004,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2005,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2005,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2006,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
2006,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2006,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2006,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2006,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2007,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2007,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2007,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2007,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2007,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2007,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2007,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2007,8,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2007,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2008,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2008,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2008,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2008,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2008,5,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2008,6,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2008,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2009,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2009,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2009,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2010,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2010,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2011,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2011,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2011,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2012,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2012,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2013,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2013,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2013,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2013,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2014,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2014,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2014,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2014,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2014,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2015,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2015,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2015,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2016,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2017,1,Hypergammaglobulinaemia benign monoclonal,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
2018,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2018,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2019,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2020,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2020,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2021,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2021,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2021,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2021,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2021,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2022,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2022,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2023,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2023,2,Injection site coldness,Injection site reactions,Administration site reactions,Genrl,N
2023,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2023,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2023,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2023,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2023,7,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2023,8,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2023,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2024,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2024,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2024,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2025,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2026,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2026,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2026,3,Headache,Headaches NEC,Headaches,Nerv,N
2026,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2026,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2026,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2026,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2027,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2027,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2028,1,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
2029,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2030,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2031,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2031,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2031,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2032,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2032,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2032,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2033,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2033,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2033,3,Headache,Headaches NEC,Headaches,Nerv,N
2033,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2033,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2033,6,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2033,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2033,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2034,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2035,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2036,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2036,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2037,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2037,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2037,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2038,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2038,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2039,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2040,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2040,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2040,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2040,4,Headache,Headaches NEC,Headaches,Nerv,N
2040,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2040,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2040,7,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
2041,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2042,1,Blood electrolytes increased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
2042,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2042,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2042,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2042,5,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2042,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2043,1,Device leakage,Device issues NEC,Device issues,Prod,N
2043,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2043,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2043,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2043,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2043,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2043,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2044,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2045,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2046,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2046,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2046,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2047,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2047,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2048,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2048,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2049,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2050,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2050,2,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2051,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2051,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2051,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2051,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2052,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2053,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2053,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2054,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2054,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2054,3,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2054,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2054,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2054,6,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2054,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2054,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2054,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2054,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2054,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2054,12,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2054,13,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2054,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2054,15,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2054,16,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2054,17,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
2054,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2055,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2056,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2056,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2057,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2058,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2059,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2059,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2060,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2060,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2060,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2061,1,Headache,Headaches NEC,Headaches,Nerv,N
2061,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2061,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2062,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2062,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2062,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2062,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2062,5,Muscle strength abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2062,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2063,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2064,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2064,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2064,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2065,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2065,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2065,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2065,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2065,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2066,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2067,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2068,1,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
2069,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
2070,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2070,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2070,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2070,4,Headache,Headaches NEC,Headaches,Nerv,N
2070,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2071,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2072,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2073,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2073,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2073,3,Lactose intolerance,Sugar intolerance (excl glucose intolerance),Food intolerance syndromes,Metab,N
2073,4,Migraine,Migraine headaches,Headaches,Nerv,N
2073,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2073,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2073,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2074,1,Migraine,Migraine headaches,Headaches,Nerv,N
2075,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2075,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2075,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2076,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2077,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2077,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2078,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2079,1,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2080,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2080,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2081,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2081,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2081,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2082,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2083,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2083,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2083,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2084,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2084,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2084,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2085,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2086,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2086,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
2086,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2087,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2088,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
2088,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2089,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2089,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2090,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2091,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2092,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2093,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2093,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2094,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2095,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2095,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2095,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2095,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2095,5,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2096,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2096,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2097,1,Injection site calcification,Injection site reactions,Administration site reactions,Genrl,N
2097,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2098,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2099,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2100,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2100,2,Headache,Headaches NEC,Headaches,Nerv,N
2100,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2100,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2100,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2100,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2101,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2101,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2101,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2101,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2101,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2101,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2101,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2101,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2102,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2102,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2102,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2103,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2103,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2103,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2103,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2104,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2104,2,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2105,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2106,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2107,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2108,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2108,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2109,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2110,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2112,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2112,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2113,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2114,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2114,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2114,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2116,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2117,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2118,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
2118,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2119,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2120,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2121,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2121,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2122,1,Diaphragmatic spasm,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
2122,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2122,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2123,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2123,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2123,3,Headache,Headaches NEC,Headaches,Nerv,N
2123,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2123,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2124,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2124,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2124,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2124,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2125,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2125,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2125,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2126,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2126,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2126,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2126,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2126,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2126,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2126,7,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2126,8,Migraine,Migraine headaches,Headaches,Nerv,N
2126,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2126,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2126,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2126,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2127,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2127,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2127,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2127,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2127,5,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2128,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2128,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2128,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2129,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2130,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2130,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2130,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2131,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2131,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2131,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2131,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2131,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2131,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2132,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2132,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2133,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2134,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2134,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2135,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2135,2,Headache,Headaches NEC,Headaches,Nerv,N
2135,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2135,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2136,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2137,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2138,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2139,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2139,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2139,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2139,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2140,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2141,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2142,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2143,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2144,1,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2145,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2145,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2145,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2145,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2145,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2145,6,Headache,Headaches NEC,Headaches,Nerv,N
2145,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2145,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2146,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2146,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2146,3,Needle fatigue,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2146,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2147,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2147,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2148,1,Device failure,Device issues NEC,Device issues,Prod,N
2148,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2149,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2149,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2150,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2150,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2151,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2151,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2151,3,Headache,Headaches NEC,Headaches,Nerv,N
2151,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2151,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2152,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2153,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2153,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2154,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2155,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2155,2,Headache,Headaches NEC,Headaches,Nerv,N
2155,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2156,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2157,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2157,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2157,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2157,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2158,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2159,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2159,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2159,3,Headache,Headaches NEC,Headaches,Nerv,N
2159,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2160,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2160,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2161,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2161,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2161,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2162,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2162,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2162,3,Headache,Headaches NEC,Headaches,Nerv,N
2162,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2163,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2163,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2163,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2164,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2165,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2165,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2166,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2166,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2166,3,Headache,Headaches NEC,Headaches,Nerv,N
2166,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2167,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2167,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2167,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2167,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2167,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2167,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2168,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2169,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2169,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2169,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2169,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2169,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2169,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2170,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2171,1,Device power source issue,Device malfunction events NEC,Device issues,Prod,N
2171,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2171,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2171,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2172,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2172,2,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
2172,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2172,4,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
2173,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2174,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2174,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2174,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2174,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2175,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2176,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
2176,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2176,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2176,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2176,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2177,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2178,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2178,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2179,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2179,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2179,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2179,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2179,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2179,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2179,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2179,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
2179,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2179,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2179,11,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2180,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2181,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2182,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2183,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2183,2,Headache,Headaches NEC,Headaches,Nerv,N
2183,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2183,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2183,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2184,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2184,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2185,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2186,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2186,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2187,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2188,1,Bone contusion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2188,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2188,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2189,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2190,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2190,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2191,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2191,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2191,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2192,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2192,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2192,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2192,4,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2192,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2192,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2193,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2193,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2194,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2194,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2194,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2195,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2196,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2196,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2196,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2197,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2198,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2198,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2199,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2199,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2199,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2200,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2200,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2201,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2201,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2202,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2202,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2202,3,Headache,Headaches NEC,Headaches,Nerv,N
2202,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2202,5,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2202,6,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2202,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2203,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2204,1,Enzyme level increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2204,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2205,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2206,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2206,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2207,1,Tachycardia paroxysmal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2208,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2209,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2210,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2210,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2210,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2210,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2211,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2212,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2212,2,Headache,Headaches NEC,Headaches,Nerv,N
2212,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2212,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2213,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2213,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2214,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2215,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2216,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2216,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2217,1,Device issue,Device issues NEC,Device issues,Prod,N
2217,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2217,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2218,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2218,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2219,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2219,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2219,3,Headache,Headaches NEC,Headaches,Nerv,N
2219,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2219,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2220,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2220,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2221,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2221,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2221,3,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2221,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2221,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2221,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2222,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2222,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2223,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2224,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2224,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2224,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2224,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2224,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2225,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2226,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2226,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2226,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2227,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2227,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2228,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2228,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2229,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2229,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2229,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2230,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2230,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2230,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2230,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2230,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2231,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2231,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2232,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2233,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2233,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2234,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2235,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2236,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2236,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2237,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2238,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2238,2,Headache,Headaches NEC,Headaches,Nerv,N
2238,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2239,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2240,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2240,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2241,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2241,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2241,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2242,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2242,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2242,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2242,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2242,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2243,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2243,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2243,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2243,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2244,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2244,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2244,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2245,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2245,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2246,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2247,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
2247,2,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2247,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2248,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2249,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2249,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2249,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2249,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2250,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2250,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2250,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2251,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2252,1,Headache,Headaches NEC,Headaches,Nerv,N
2252,2,Vaccination complication,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2253,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2253,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2254,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2255,1,Headache,Headaches NEC,Headaches,Nerv,N
2256,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2257,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2257,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2257,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2257,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2258,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2259,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2260,1,Headache,Headaches NEC,Headaches,Nerv,N
2260,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2260,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2260,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2261,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2261,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2262,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2262,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2262,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2262,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2263,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2264,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2264,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2265,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2265,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2266,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2266,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
2266,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2267,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2268,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2268,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2268,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
2268,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2269,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2269,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2270,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2270,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2270,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2271,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2272,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2273,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2273,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2273,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2274,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2274,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2275,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2275,2,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
2276,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2276,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2277,1,Administration site wound,Administration site reactions NEC,Administration site reactions,Genrl,N
2277,2,Haematological infection,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2277,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2278,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2278,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2279,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2279,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2280,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2281,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2282,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2283,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2284,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2284,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2284,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2284,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2285,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2285,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2285,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2286,1,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
2286,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
2286,3,Device failure,Device issues NEC,Device issues,Prod,N
2286,4,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2286,5,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2286,6,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2286,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2286,8,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2286,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2286,10,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2286,11,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2286,12,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2286,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2286,14,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
2286,15,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2286,16,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2287,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2287,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2287,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2288,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2288,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2289,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2290,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2290,2,Complication of device removal,Complications associated with device NEC,Complications associated with device,Genrl,N
2290,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2290,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2290,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2291,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2291,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2291,3,Headache,Headaches NEC,Headaches,Nerv,N
2292,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2292,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2292,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2292,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2292,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2292,6,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2292,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2292,8,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2292,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2293,1,Headache,Headaches NEC,Headaches,Nerv,N
2293,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2293,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2294,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2295,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2295,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2295,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2295,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2296,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2297,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2298,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2298,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2298,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2298,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2298,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2298,6,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2299,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2299,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2299,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2299,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2300,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2300,2,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
2301,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2301,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2301,3,Headache,Headaches NEC,Headaches,Nerv,N
2301,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2302,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2302,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2303,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2303,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2303,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2304,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2305,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
2305,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2306,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2307,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2307,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2307,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2307,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2307,5,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2307,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2307,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2307,8,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2307,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2308,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2308,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2309,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2310,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2311,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2312,1,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2313,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2314,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2314,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2315,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2315,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2315,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2315,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2315,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2316,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2316,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2316,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2316,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2317,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2317,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2318,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2319,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2320,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2320,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2320,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2321,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2321,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2321,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2322,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2322,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2322,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2322,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2322,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2323,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2323,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2324,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2325,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2325,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2326,1,Complicated appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2326,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2326,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2327,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2327,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2328,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2329,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2329,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2330,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2331,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2331,2,Gastrointestinal procedural complication,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2332,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2332,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2333,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2333,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2333,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2334,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2334,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2334,3,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2335,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2335,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2336,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2336,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2337,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2338,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2339,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2340,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2340,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2341,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2341,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2342,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2343,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2343,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2344,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2344,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2345,1,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2345,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2345,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2345,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2346,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2346,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2346,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2347,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2347,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2347,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2347,4,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2348,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
2349,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2350,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2351,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2351,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2351,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2351,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2352,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2353,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2354,1,Psychological trauma,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2354,2,Respiratory fume inhalation disorder,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2355,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2356,1,Headache,Headaches NEC,Headaches,Nerv,N
2357,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2358,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2359,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2360,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2361,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2362,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2362,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2363,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2363,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2364,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2364,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2365,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2365,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2365,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2365,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
2365,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2365,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2365,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2366,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2366,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2367,1,Headache,Headaches NEC,Headaches,Nerv,N
2367,2,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2367,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2368,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2368,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2368,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2368,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2369,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2369,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2370,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2371,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2372,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2372,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2372,3,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2372,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2373,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
2374,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2375,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2375,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2376,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2376,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2377,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2377,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2377,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2377,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2378,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2379,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2380,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2381,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2381,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2381,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2382,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2383,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2384,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2385,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2386,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2387,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2387,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2387,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2388,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2389,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2390,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2390,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2390,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2391,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2392,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2393,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2393,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2394,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2395,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2395,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2396,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2397,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2397,2,Hepatic enzyme decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2397,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2397,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2397,5,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2397,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2398,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2398,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2398,3,Headache,Headaches NEC,Headaches,Nerv,N
2398,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2399,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2400,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2401,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2402,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2403,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
2404,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2404,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2405,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2405,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2405,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2405,4,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2406,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2406,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2407,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2407,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2407,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2408,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2409,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2409,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2409,3,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2410,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2411,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2411,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2411,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2411,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
2411,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2411,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
2411,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2412,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2413,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2413,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2414,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2414,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2415,1,Band sensation,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2415,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2415,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2416,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2417,1,Headache,Headaches NEC,Headaches,Nerv,N
2417,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2418,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2418,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2418,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2419,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2420,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2421,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2421,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2421,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2422,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2422,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2422,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2423,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2424,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2425,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2425,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2425,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2426,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2427,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2428,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2428,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2428,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2429,1,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
2429,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2430,1,Brain neoplasm benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
2431,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2431,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2431,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2432,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2434,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2435,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2435,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2435,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2436,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2437,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2438,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2439,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2439,2,Migraine,Migraine headaches,Headaches,Nerv,N
2440,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2441,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2442,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2443,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2443,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2444,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2444,2,Febrile convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2444,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2444,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
2445,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2445,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2446,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2446,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2447,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2448,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2448,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2449,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2449,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2449,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2450,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2450,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2450,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2451,1,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2451,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2452,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2452,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2453,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2454,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2454,2,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
2455,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2456,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2456,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2456,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2457,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2457,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2457,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2457,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2457,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2458,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2458,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2458,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2459,1,Headache,Headaches NEC,Headaches,Nerv,N
2460,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2460,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2461,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2461,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2462,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2462,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2463,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2463,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2464,1,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2465,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2465,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2465,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2465,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2466,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2467,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2468,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2469,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2469,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2470,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2470,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2470,3,Skeletal injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2471,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2472,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2472,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2472,3,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2472,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2472,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2473,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2473,2,Headache,Headaches NEC,Headaches,Nerv,N
2473,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2473,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2474,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2475,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2476,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2476,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2477,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2477,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2477,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2478,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2478,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2479,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2480,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2481,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2482,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2483,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2484,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2484,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2485,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2485,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2485,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2486,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2487,1,Injection site hypertrophy,Injection site reactions,Administration site reactions,Genrl,N
2487,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2488,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2488,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2488,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2488,4,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2488,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2488,6,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2488,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2488,8,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2488,9,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2488,10,Headache,Headaches NEC,Headaches,Nerv,N
2488,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2489,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2489,2,Drug titration error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2489,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2489,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2489,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2489,6,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2490,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2490,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2490,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2491,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2491,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2491,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2491,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2491,5,Helicobacter test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2491,6,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2491,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2491,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2491,9,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2491,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2491,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2491,12,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2491,13,Red blood cell count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2491,14,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2492,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2493,1,Device issue,Device issues NEC,Device issues,Prod,N
2493,2,Headache,Headaches NEC,Headaches,Nerv,N
2493,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2493,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2493,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2493,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2494,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
2495,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2496,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2496,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2497,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2498,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2499,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2500,1,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2500,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2500,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2501,1,Headache,Headaches NEC,Headaches,Nerv,N
2501,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2502,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2502,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2503,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2504,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2504,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2504,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2505,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2505,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2505,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2506,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2507,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2507,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2508,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2508,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2508,3,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
2508,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2509,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2510,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2511,1,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2511,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2511,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2511,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2511,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2512,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2513,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2514,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
2514,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2514,3,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2515,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2515,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2515,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2515,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2515,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2515,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2516,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2516,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2517,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2517,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2517,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2517,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2517,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2517,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2518,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2518,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2519,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2520,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2520,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2520,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2521,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2521,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2521,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2521,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2522,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2522,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2523,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2524,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2525,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2525,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2525,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2525,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2525,5,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
2526,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2527,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2527,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2528,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2528,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2528,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2529,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2530,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2530,2,Headache,Headaches NEC,Headaches,Nerv,N
2530,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2530,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2530,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2531,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2531,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2531,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2532,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2533,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2534,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2534,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2534,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2534,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2534,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2534,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2534,7,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
2535,1,Headache,Headaches NEC,Headaches,Nerv,N
2536,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2536,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2536,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2536,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2537,1,Device issue,Device issues NEC,Device issues,Prod,N
2537,2,Migraine,Migraine headaches,Headaches,Nerv,N
2538,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2539,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2539,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2539,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2540,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2541,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2541,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2541,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2542,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2543,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
2543,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2543,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2543,4,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2543,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2544,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2544,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2545,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2545,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2546,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2546,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2547,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2547,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2547,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2547,4,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2548,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2549,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2550,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2550,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2550,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2550,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2550,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2551,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2551,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2551,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2552,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2553,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2554,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2555,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2555,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2555,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2556,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2556,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2556,3,Headache,Headaches NEC,Headaches,Nerv,N
2556,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2557,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2558,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2558,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2559,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2560,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2561,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2561,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2562,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2562,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2563,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2564,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2565,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2566,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2566,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2566,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2567,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
2567,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2567,3,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2568,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2568,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2568,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2568,4,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2569,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2570,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2570,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2571,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2571,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2571,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2571,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2571,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2571,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2571,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2571,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2571,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2571,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2571,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2571,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2572,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2572,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2572,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2573,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2573,2,Unknown schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2574,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2574,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2574,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2574,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2575,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2575,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2576,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2577,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2577,2,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2577,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2578,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2578,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2579,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2580,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2580,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2581,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2581,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2581,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2582,1,Headache,Headaches NEC,Headaches,Nerv,N
2582,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2582,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2583,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2583,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2583,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2584,1,Anaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2584,2,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2584,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2584,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2584,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2584,6,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2584,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2584,8,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
2584,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2585,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2585,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2585,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2585,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2586,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2586,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2588,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2588,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2588,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2588,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2589,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2589,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2589,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2589,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2589,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2589,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2589,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2590,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2591,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2591,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2592,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2592,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2593,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2593,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2593,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2593,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2594,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2595,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2596,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2597,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2598,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2598,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2599,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2600,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2601,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2601,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2601,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2602,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2602,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2602,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2602,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2603,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2604,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2604,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2604,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2604,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2604,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2605,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2606,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2607,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2607,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2608,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2608,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2608,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2609,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2610,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2610,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2610,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2610,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2610,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2611,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2612,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2613,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2614,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2614,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2614,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2614,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2614,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2615,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2615,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2615,3,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
2615,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2615,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2616,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2617,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2617,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2617,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2618,1,Headache,Headaches NEC,Headaches,Nerv,N
2618,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2618,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2618,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2619,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2619,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2620,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2620,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2621,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2621,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2621,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2621,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2622,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2623,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2623,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2623,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2623,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2624,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2624,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2624,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2625,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2626,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2626,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2626,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2626,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2627,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2628,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2629,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2630,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2631,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2632,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2632,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2632,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2632,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2632,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2633,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2634,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2634,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2634,3,Headache,Headaches NEC,Headaches,Nerv,N
2634,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2635,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2635,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2635,3,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2635,4,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
2636,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2637,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2637,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2637,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2638,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2639,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2640,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2640,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2640,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2641,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2641,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2642,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2643,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2643,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2644,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
2645,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2646,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2646,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2647,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2648,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2649,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2650,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2651,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2652,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2653,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2653,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2654,1,Headache,Headaches NEC,Headaches,Nerv,N
2654,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2655,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2655,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2655,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2655,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2656,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2657,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2658,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2658,2,Headache,Headaches NEC,Headaches,Nerv,N
2658,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2658,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2659,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2660,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2661,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2661,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2661,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2662,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2662,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2663,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2664,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2664,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2665,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2666,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2666,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2667,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2668,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2669,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2669,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2669,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2670,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2670,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2670,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2670,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2670,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2671,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2671,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2671,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2671,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2672,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2672,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2673,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
2673,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2674,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2675,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2676,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2676,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2677,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2677,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2677,3,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2678,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2679,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2680,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2680,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2680,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2680,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2680,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2680,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2680,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2680,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2680,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2681,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2682,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2682,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2683,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2684,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2684,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2685,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2685,2,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
2686,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2687,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2687,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
2687,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2687,4,Scarlet fever,Streptococcal infections,Bacterial infectious disorders,Infec,N
2688,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2688,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2688,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2689,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2690,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2690,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2691,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2691,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2691,3,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
2691,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2692,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2692,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2693,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2694,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2694,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2694,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2694,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2695,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2696,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2697,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2697,2,Headache,Headaches NEC,Headaches,Nerv,N
2697,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2697,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2697,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2698,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2699,1,Headache,Headaches NEC,Headaches,Nerv,N
2699,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2700,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2700,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2701,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2702,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2702,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2703,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2703,2,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2703,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2703,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2703,5,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2704,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2705,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2706,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2706,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2706,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2706,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2706,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2707,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2708,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2708,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2708,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2708,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2709,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2710,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2710,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2711,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2712,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2712,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2713,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2714,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2715,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2716,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2716,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2717,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2717,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2717,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2718,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
2719,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2720,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2720,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2720,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2720,4,Headache,Headaches NEC,Headaches,Nerv,N
2720,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2720,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2720,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2720,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2721,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2722,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2722,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2723,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2723,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2723,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2723,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2723,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2723,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2723,7,Headache,Headaches NEC,Headaches,Nerv,N
2723,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2723,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2723,10,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2723,11,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2723,12,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2723,13,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2723,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2723,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2723,16,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2723,17,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2724,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2725,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2726,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2727,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2727,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2727,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2728,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2729,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2729,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2730,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2730,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2730,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2730,4,Migraine,Migraine headaches,Headaches,Nerv,N
2730,5,Post procedural discomfort,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2731,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2731,2,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2732,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
2732,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2733,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2733,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2733,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2733,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2734,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2734,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2734,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2734,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2734,5,Headache,Headaches NEC,Headaches,Nerv,N
2734,6,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2734,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2735,1,Headache,Headaches NEC,Headaches,Nerv,N
2736,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2736,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2737,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2738,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2739,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2739,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2739,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
2739,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2740,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2740,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2740,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2740,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2740,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2740,6,Headache,Headaches NEC,Headaches,Nerv,N
2740,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2740,8,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2740,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2740,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2740,11,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2740,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2741,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2742,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2743,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2744,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2744,2,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2745,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2745,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2746,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2746,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2747,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2747,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2748,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2748,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2748,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2749,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2750,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2750,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2751,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2752,1,Migraine,Migraine headaches,Headaches,Nerv,N
2753,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2754,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2754,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2754,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2755,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2755,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2756,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2756,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2756,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2756,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2756,5,Migraine,Migraine headaches,Headaches,Nerv,N
2756,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2757,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2757,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2758,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2758,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2758,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2759,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2760,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
2760,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2761,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2761,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2762,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2762,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2762,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2763,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2763,2,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2764,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2765,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2765,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2765,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2766,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2767,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2768,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2769,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2769,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2769,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2770,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2771,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2772,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2773,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2774,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2775,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2775,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2775,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2775,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2775,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2775,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2776,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2776,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2777,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2777,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2778,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2779,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
2779,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2779,3,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2780,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2781,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2781,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2781,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2782,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2783,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2784,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2784,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2785,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2786,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2786,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2786,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2786,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2787,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2788,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2789,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2789,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2790,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2790,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2790,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2791,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2792,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2793,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2794,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2794,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2794,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2794,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2795,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2795,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2795,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2796,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2797,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2797,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2797,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2797,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2797,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2797,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2798,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2798,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2799,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2800,1,Headache,Headaches NEC,Headaches,Nerv,N
2800,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2801,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2801,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2801,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2802,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2802,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2802,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2803,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2804,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2805,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2806,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2806,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2807,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2808,1,Headache,Headaches NEC,Headaches,Nerv,N
2808,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2808,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2808,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2809,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2809,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2809,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2810,1,Cutaneous symptom,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2810,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2811,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2811,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2813,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2814,1,Venous injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
2815,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2816,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2816,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2816,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2816,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2817,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
2817,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2818,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2818,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2819,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2819,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2820,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2821,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2822,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2822,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2823,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2823,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2824,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2825,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2826,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2826,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2827,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2828,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2829,1,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
2829,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2829,3,Injection site exfoliation,Injection site reactions,Administration site reactions,Genrl,N
2829,4,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
2829,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2829,6,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
2830,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2830,2,Headache,Headaches NEC,Headaches,Nerv,N
2830,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2830,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2830,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2830,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2831,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2832,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2832,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2832,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2833,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2834,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2834,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2834,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
2834,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2835,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2836,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2836,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2836,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2836,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2836,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2837,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2838,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2838,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2838,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2838,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2839,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2840,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2840,2,Headache,Headaches NEC,Headaches,Nerv,N
2840,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2841,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2842,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2842,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2843,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2844,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2845,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2846,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2847,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2848,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2849,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2850,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2850,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2851,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2851,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2852,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2853,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2853,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2853,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2854,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2855,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2856,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2856,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2857,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2858,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2859,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2859,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2859,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2859,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2860,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2860,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2860,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2861,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2861,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2861,3,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2862,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2863,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2863,2,Headache,Headaches NEC,Headaches,Nerv,N
2863,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2864,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2864,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2865,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2865,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2865,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2865,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2865,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2866,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2867,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2868,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2869,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2870,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2871,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2871,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2871,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2871,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2872,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2873,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2874,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2874,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2874,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2875,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2876,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
2876,2,Inadequate aseptic technique in use of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2876,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2876,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2877,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2877,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2878,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2878,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2879,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2879,2,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2880,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2880,2,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2880,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2881,1,Headache,Headaches NEC,Headaches,Nerv,N
2882,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2883,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2883,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2883,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2883,4,Headache,Headaches NEC,Headaches,Nerv,N
2883,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2883,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2884,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2885,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2886,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2886,2,Headache,Headaches NEC,Headaches,Nerv,N
2886,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2887,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2887,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2888,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
2889,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2890,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2891,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2891,2,Migraine,Migraine headaches,Headaches,Nerv,N
2891,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2892,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2892,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2892,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2893,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2894,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2894,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2895,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2896,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2897,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2897,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2898,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2899,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2899,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2900,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2901,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2901,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2902,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2902,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2903,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2904,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2904,2,Hemihypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2904,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2905,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2906,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2906,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2906,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2906,4,Needle fatigue,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2906,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2907,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2908,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2908,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2909,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2909,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2910,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2910,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2911,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2911,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2912,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
2912,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
2912,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2913,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2913,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2914,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2915,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2915,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2915,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2915,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2915,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2915,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2915,7,Migraine,Migraine headaches,Headaches,Nerv,N
2915,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2915,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2916,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2917,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2917,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2918,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2918,2,Device failure,Device issues NEC,Device issues,Prod,N
2918,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2919,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2919,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2920,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
2920,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
2920,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2920,4,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2920,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2921,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
2922,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2922,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2923,1,Headache,Headaches NEC,Headaches,Nerv,N
2923,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2924,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2924,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2924,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2924,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2924,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2925,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2925,2,Headache,Headaches NEC,Headaches,Nerv,N
2926,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2926,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2926,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2926,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2926,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2927,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2928,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2928,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2929,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2930,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2931,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2931,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2931,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2932,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2933,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2933,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
2933,3,Migraine,Migraine headaches,Headaches,Nerv,N
2933,4,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2934,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2935,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2935,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2935,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2936,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2936,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2937,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2937,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2938,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2939,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2939,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2939,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2939,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2939,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2940,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2941,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2941,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2942,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2942,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2942,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2943,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2943,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2943,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2943,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2944,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2944,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2944,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2944,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2944,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2945,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2945,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2945,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
2946,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2947,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2947,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2947,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2947,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2947,5,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
2947,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2947,7,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2947,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2947,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2947,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2947,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2948,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2949,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
2950,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2950,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2950,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2950,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2951,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2952,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2953,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2953,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2954,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2954,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2955,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2956,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2957,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2957,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2957,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2957,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2958,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2959,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2959,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2959,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2959,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2960,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2960,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2960,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2960,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2961,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2961,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2962,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2962,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2962,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2963,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2964,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2964,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
2964,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
2964,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2965,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2965,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2965,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2966,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2966,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2966,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2967,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2967,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2968,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2968,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2968,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2968,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2969,1,Headache,Headaches NEC,Headaches,Nerv,N
2969,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2969,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2970,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2970,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2971,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2971,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2972,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2972,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2972,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2973,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2973,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2973,3,Headache,Headaches NEC,Headaches,Nerv,N
2973,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2973,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2974,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2975,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2976,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2976,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2976,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2976,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2976,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2977,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2977,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2977,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2978,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2978,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2978,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2979,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2979,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2980,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2981,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2981,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2981,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2982,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2983,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2984,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2984,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2984,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2984,4,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2985,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2986,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2987,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2988,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2989,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2989,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2990,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2990,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2990,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2991,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2992,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2992,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2993,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2993,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2993,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2993,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2994,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2994,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2994,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2995,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2995,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2995,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2996,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2996,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2997,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2997,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2998,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2999,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3000,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3001,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3001,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3001,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3002,1,Headache,Headaches NEC,Headaches,Nerv,N
3002,2,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
3002,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3003,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3003,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
3004,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3004,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3004,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3005,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3005,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3005,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3005,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3005,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3005,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3005,7,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3006,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3006,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3006,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3006,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3006,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3006,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3006,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3007,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3007,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3007,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3007,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3007,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3008,1,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3008,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
3009,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3009,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3009,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3009,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3009,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3010,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3010,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3010,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3011,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3011,2,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3011,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3012,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3013,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3013,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3013,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3014,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3014,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3014,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3014,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3015,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3017,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3017,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3017,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3018,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3018,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3018,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3018,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3019,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3020,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3020,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3020,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3021,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3021,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3021,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3021,4,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
3022,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3023,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3024,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3025,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3025,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3025,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3025,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3025,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3025,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3025,7,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3025,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3025,9,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3025,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3025,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3026,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3026,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3026,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3026,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3026,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3026,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3027,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3028,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3029,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3030,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3030,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3030,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3031,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3032,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3032,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3032,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3033,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3034,1,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
3034,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3035,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3035,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3036,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3037,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3037,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3038,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3039,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3040,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3040,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3040,3,Headache,Headaches NEC,Headaches,Nerv,N
3040,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3041,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3042,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3042,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3042,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3043,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3044,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3044,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3044,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3044,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3045,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3045,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3045,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3046,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3046,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3047,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3048,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3049,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3049,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3049,3,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3050,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3050,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3050,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3051,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3051,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3052,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3053,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3053,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3054,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3054,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3055,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3056,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3057,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3057,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3058,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3058,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3058,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
3058,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3058,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3058,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3059,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3059,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3060,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3060,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3061,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3061,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3061,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3061,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3061,5,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3062,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3062,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3062,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3063,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3063,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3064,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3064,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3064,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3064,4,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3064,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3065,1,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
3065,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3066,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3066,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3067,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
3068,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3068,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3069,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3070,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3070,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3071,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3071,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3071,3,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
3071,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3071,5,Headache,Headaches NEC,Headaches,Nerv,N
3071,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3071,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3072,1,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3072,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3073,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3074,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3074,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3074,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3074,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3075,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3076,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3077,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3077,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3077,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3077,4,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3077,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3078,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3078,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
3078,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
3079,1,Device issue,Device issues NEC,Device issues,Prod,N
3079,2,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3079,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3080,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3081,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3081,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3082,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3082,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3082,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3082,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3082,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3082,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3082,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3082,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
3083,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3084,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3084,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3084,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3084,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3085,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3085,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3086,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3086,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3087,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3087,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3087,3,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3088,1,Joint destruction,Joint related disorders NEC,Joint disorders,Musc,N
3089,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3089,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3089,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3090,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3090,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3090,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3090,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3091,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3092,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3092,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3092,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3092,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3093,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3094,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3095,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3096,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3097,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3097,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3098,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3099,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3100,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3100,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3100,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3100,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
3101,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3102,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3102,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3103,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3103,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3103,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3103,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3104,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3105,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3106,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3106,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3107,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3107,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3108,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3108,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3108,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3109,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3109,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3109,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3109,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3109,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3110,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3111,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3112,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3113,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3114,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3115,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3115,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3115,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3116,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3116,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3117,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3117,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3118,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3119,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3120,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3120,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3121,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3121,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3121,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3122,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3122,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3122,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3122,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3123,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3123,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
3124,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3125,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3126,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3126,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3126,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3126,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3126,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
3127,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3127,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3128,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3129,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3130,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3130,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3131,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3132,1,Headache,Headaches NEC,Headaches,Nerv,N
3132,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3132,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3132,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3133,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3134,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3135,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3136,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3137,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3137,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3137,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3137,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3138,1,Obstruction gastric,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
3139,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3139,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3139,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3139,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3139,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3140,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3141,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3142,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3142,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3142,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3143,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3144,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3144,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3144,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3144,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3144,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3144,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3145,1,Headache,Headaches NEC,Headaches,Nerv,N
3146,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3147,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3147,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3147,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
3148,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3149,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3149,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3150,1,Device dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3150,2,Device issue,Device issues NEC,Device issues,Prod,N
3150,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3150,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3151,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3152,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3152,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
3153,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3154,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3155,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3155,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3155,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3156,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3157,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3158,1,Bone density abnormal,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
3158,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3158,3,Renal surgery,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3159,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3160,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3161,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3162,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3163,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3163,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3164,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3164,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3165,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3166,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3167,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3167,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3167,3,Stress at work,Employment issues,Economic and housing issues,SocCi,N
3168,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3169,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3170,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3171,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3171,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3171,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3172,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3172,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3172,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3173,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3173,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3173,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3173,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3174,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3174,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3174,3,Headache,Headaches NEC,Headaches,Nerv,N
3174,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3175,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3176,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3177,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3177,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3178,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3179,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3179,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3180,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
3181,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3182,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3183,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3184,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3184,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3186,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3186,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3186,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3187,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3188,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3189,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3190,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3190,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3190,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
3190,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3190,5,Small intestine neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
3190,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3191,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3191,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3192,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3192,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3192,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3193,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3194,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3194,2,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
3195,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
3195,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3196,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3197,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3197,2,Headache,Headaches NEC,Headaches,Nerv,N
3197,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3198,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3199,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3200,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
3200,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3200,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3201,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3201,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3202,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3203,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3203,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3204,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3205,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3206,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3207,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3208,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3208,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3209,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3209,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3210,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3210,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3211,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3211,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3211,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3211,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
3211,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3211,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
3212,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3212,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3212,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
3213,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3214,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3214,2,Headache,Headaches NEC,Headaches,Nerv,N
3214,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3214,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3214,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3215,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3215,2,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3216,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3217,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3218,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3219,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3220,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3221,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3222,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3223,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3224,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3224,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3225,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3226,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3226,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3227,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3227,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3227,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3227,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3228,1,Term baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3229,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3230,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3230,2,Headache,Headaches NEC,Headaches,Nerv,N
3231,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3232,1,Cutaneous sarcoidosis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
3232,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3233,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3233,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3234,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3234,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3235,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3236,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3236,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3237,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3238,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3239,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3239,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3239,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3239,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3240,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3240,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3240,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3241,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3242,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3242,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3243,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3244,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3245,1,Device issue,Device issues NEC,Device issues,Prod,N
3245,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3245,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3245,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3245,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3246,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3246,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3246,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
3247,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3248,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
3249,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3249,2,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3250,1,Headache,Headaches NEC,Headaches,Nerv,N
3250,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3251,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3251,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3252,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3253,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3254,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3254,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3254,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3255,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3256,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3256,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3256,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3256,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3256,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3257,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3257,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3257,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3258,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3258,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3259,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3260,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3261,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3262,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3262,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3262,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3263,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3264,1,Headache,Headaches NEC,Headaches,Nerv,N
3265,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3266,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3266,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3266,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3267,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3267,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3268,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3269,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3270,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3271,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3271,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3271,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3272,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3272,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3273,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3274,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3275,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3276,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3277,1,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3278,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3278,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3279,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3280,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3281,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3282,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3282,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3283,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3283,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3284,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3285,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3286,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3287,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3288,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3288,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3289,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3289,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3290,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3290,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3291,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3291,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3291,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3292,1,Cestode infection,Cestode infections,Helminthic disorders,Infec,N
3293,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3294,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3294,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3295,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3297,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3298,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3298,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3299,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3300,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3300,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3301,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3301,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3301,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3302,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3302,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3303,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3304,1,Drug delivery system issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3304,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3304,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3305,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3306,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3306,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3306,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3306,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3306,5,Headache,Headaches NEC,Headaches,Nerv,N
3306,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3306,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3307,1,Migraine,Migraine headaches,Headaches,Nerv,N
3307,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3307,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3308,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3308,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
3308,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3309,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3310,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3310,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3311,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3311,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3311,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3312,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3313,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3314,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
3315,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3315,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3316,1,Device issue,Device issues NEC,Device issues,Prod,N
3316,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3317,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3317,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3318,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3318,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3319,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3320,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3320,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3321,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3321,2,Headache,Headaches NEC,Headaches,Nerv,N
3321,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3321,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3321,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3321,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3322,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3323,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3324,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3324,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3325,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3326,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3327,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3327,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3328,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3329,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3329,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3329,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3329,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3329,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
3330,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3331,1,Migraine,Migraine headaches,Headaches,Nerv,N
3332,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3332,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3333,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3333,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3334,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3335,1,Headache,Headaches NEC,Headaches,Nerv,N
3335,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3336,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3336,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3337,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3338,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3339,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3340,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3340,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3340,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3341,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3341,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3342,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3342,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3343,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3343,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3343,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3344,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3344,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3345,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3346,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3346,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3346,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3347,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3347,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3348,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3349,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3350,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3351,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3352,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3353,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3353,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3353,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3354,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3354,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3355,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3355,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3355,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3356,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3356,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3356,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3357,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3357,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3358,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3359,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3360,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3360,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3361,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
3361,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3361,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3362,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3363,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3363,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3364,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3365,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3365,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3366,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3367,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3368,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3368,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3368,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3368,4,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
3368,5,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
3368,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3368,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3369,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3369,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3370,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3370,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3371,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
3372,1,Headache,Headaches NEC,Headaches,Nerv,N
3372,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3373,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3374,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3374,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
3374,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3374,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3374,5,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3375,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3375,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3376,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3377,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3377,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3378,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3378,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3378,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3379,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3379,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3380,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3381,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3381,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3382,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3382,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3383,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3384,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3384,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3385,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3386,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3386,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3386,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3387,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3387,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3387,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
3387,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3387,5,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3388,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3389,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3389,2,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3390,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
3390,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
3391,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3391,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3391,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3391,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3392,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3392,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3392,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3393,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3393,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3393,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3393,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3394,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3394,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3394,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3394,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3394,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3394,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3394,7,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3395,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3396,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3397,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3398,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3398,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3399,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3400,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3401,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3401,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3402,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3402,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3403,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3404,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3405,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3406,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3407,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3408,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3409,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3410,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3411,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3411,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3412,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
3412,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3412,3,Peripheral nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
3412,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3413,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3413,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3414,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3415,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3416,1,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3417,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3418,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3418,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3419,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3420,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3421,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3422,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3423,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3424,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3425,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3426,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3427,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3428,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3429,1,Headache,Headaches NEC,Headaches,Nerv,N
3430,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3430,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3430,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3431,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3432,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3432,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3433,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3433,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3434,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3434,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3434,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3435,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3435,2,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
3436,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3436,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3437,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3438,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3438,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3438,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3439,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3440,1,Hand deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3440,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3441,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3441,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3442,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3443,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3444,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3445,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3445,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3446,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3447,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3447,2,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3447,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3447,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3447,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
3447,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3447,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3447,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3447,9,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3448,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3448,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3448,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3448,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
3448,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3448,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3449,1,Enzyme level increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3450,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3451,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3451,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3451,3,Headache,Headaches NEC,Headaches,Nerv,N
3451,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3452,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3453,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3454,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3455,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3455,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3456,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3456,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3456,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3457,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3458,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3459,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3460,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3460,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3460,3,Headache,Headaches NEC,Headaches,Nerv,N
3460,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3461,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3462,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3463,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3464,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3464,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3464,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3464,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3464,5,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3465,1,Measles,Rubeola viral infections,Viral infectious disorders,Infec,N
3466,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3467,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3468,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3468,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3468,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3469,1,Malignant neoplasm of eye,Ocular neoplasms malignant (excl melanomas),Ocular neoplasms,Neopl,N
3470,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3470,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3470,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3470,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3470,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3471,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3472,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3473,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3474,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3474,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3475,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3475,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3475,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3475,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3475,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3475,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3476,1,Vertebral osteophyte,Osteoarthropathies,Joint disorders,Musc,N
3477,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3478,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3479,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3479,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3480,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3480,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3481,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3482,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3483,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
3484,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3485,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3486,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3487,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3488,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3488,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
3488,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3488,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3489,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3490,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3491,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3492,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3493,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3494,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
3494,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3494,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3494,4,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3495,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3496,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3496,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3497,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3497,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3498,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3499,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3500,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
3500,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3500,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3501,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3501,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3501,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
3501,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3501,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3501,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3502,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3502,2,Headache,Headaches NEC,Headaches,Nerv,N
3502,3,Injection site eczema,Injection site reactions,Administration site reactions,Genrl,N
3502,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3502,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3503,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3503,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3504,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3505,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3506,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3507,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3507,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3507,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3508,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3509,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3509,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3510,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3510,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3511,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3511,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3512,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3512,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3513,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3513,2,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
3514,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3514,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3515,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3516,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3516,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3517,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3517,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3518,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3518,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3519,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3520,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3520,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3520,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3520,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3521,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3522,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3523,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3524,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3525,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3525,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3525,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3526,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3527,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3528,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3529,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3530,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3530,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3530,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3530,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3530,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3530,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3531,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3532,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3533,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3533,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3533,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3533,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3534,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3535,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
3535,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3536,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3536,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3536,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3536,4,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
3536,5,Knee deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3536,6,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
3536,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3537,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
3537,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3537,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3538,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3538,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3538,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3538,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3538,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3538,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3539,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3540,1,Headache,Headaches NEC,Headaches,Nerv,N
3541,1,Failed forceps delivery,Reproductive tract and breast procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3541,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3541,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3541,4,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
3542,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3542,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3543,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3543,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3543,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
3544,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
3545,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3546,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
3546,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3547,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3548,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3549,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3549,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3549,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3549,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3549,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3549,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3550,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3551,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3551,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3552,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3552,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3552,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3552,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3553,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3553,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3554,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3554,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3555,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3555,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3556,1,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
3556,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3556,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3557,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3558,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3559,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3559,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3560,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3561,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3562,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3563,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3564,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3565,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3565,2,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3566,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3566,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3567,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3568,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3568,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3568,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3568,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3568,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3569,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3569,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3570,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3571,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3571,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3572,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3572,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3573,1,Immobile,Disability issues,Lifestyle issues,SocCi,N
3574,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3575,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3575,2,Headache,Headaches NEC,Headaches,Nerv,N
3576,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3577,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3577,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3578,1,Migraine,Migraine headaches,Headaches,Nerv,N
3579,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3579,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3580,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3580,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3581,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3582,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3583,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3584,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3584,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3584,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3584,4,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
3585,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3586,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3587,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3588,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3588,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3589,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3590,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3591,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
3591,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3592,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3592,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3592,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3593,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3593,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3594,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3594,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3595,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3596,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3597,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3598,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3598,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3598,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3598,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3599,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
3599,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3599,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3600,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
3600,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3601,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3602,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3603,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3604,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3604,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3604,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3605,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3605,2,Migraine,Migraine headaches,Headaches,Nerv,N
3606,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3606,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
3607,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3607,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3608,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3609,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3610,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3611,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3611,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3612,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3612,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3612,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3612,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3613,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3613,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3613,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3613,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3614,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3615,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3616,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3617,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3617,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3618,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3618,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
